Methodological challenges of developing a tool to measure patient recall and understanding from a Haematopoietic Stem Cell Transplantation (HSCT) consultation by Iqbal, Shehnaz
Glasgow Theses Service 
http://theses.gla.ac.uk/ 
theses@gla.ac.uk 
 
 
 
 
 
Iqbal, Shehnaz (2014) Methodological challenges of developing a tool to 
measure patient recall and understanding from a Haematopoietic Stem 
Cell Transplantation (HSCT) consultation. D Clin Psy thesis. 
 
 
http://theses.gla.ac.uk/5988/ 
 
 
 
Copyright and moral rights for this thesis are retained by the author 
 
A copy can be downloaded for personal non-commercial research or 
study, without prior permission or charge 
 
This thesis cannot be reproduced or quoted extensively from without first 
obtaining permission in writing from the Author 
 
The content must not be changed in any way or sold commercially in any 
format or medium without the formal permission of the Author 
 
When referring to this work, full bibliographic details including the 
author, title, awarding institution and date of the thesis must be given 
 
0  
Methodological challenges of developing a tool to 
measure patient recall and understanding from a 
Haematopoietic Stem Cell Transplantation (HSCT) 
consultation 
 
and 
 
Clinical Research Portfolio 
 
Volume I 
 
(Volume II bound separately) 
 
 
Shehnaz Iqbal 
 
 
Submitted in partial fulfilment of the requirements for the degree of 
Doctorate in Clinical Psychology (DClinPsy) 
 
Institute of Health and Wellbeing 
College of Medical, Veterinary and Life Sciences 
University of Glasgow 
 
 
September 2014 
 
 
 
 
1  
 
Declaration of Originality Form 
This form must be completed and signed and submitted with all assignments. 
Please complete the information below (using BLOCK CAPITALS). 
 
 
Name ...................SHEHNAZ IQBAL...................................................... 
 
Student Number ..........1005260............................................................ 
 
Course Name .....DOCTORATE IN CLINICAL PSYCHOLOGY.............................................. 
 
Assignment Number/Name.............CLINICAL RESEARCH PORTFOLIO............................ 
An extract from the University’s Statement on Plagiarism is provided overleaf. Please read 
carefully THEN read and sign the declaration below. 
I confirm that this assignment is my own work and that I have: 
Read and understood the guidance on plagiarism in the Student Handbook, 
including the University of Glasgow Statement on Plagiarism 
 
 
Clearly referenced, in both the text and the bibliography or references, all sources 
used in the work 
 

Fully referenced (including page numbers) and used inverted commas for all text 
quoted from books, journals, web etc. (Please check with the Department which 
referencing style is to be used) 
 
 
Provided the sources for all tables, figures, data etc. that are not my own work  
Not made use of the work of any other student(s) past or present without 
acknowledgement. This includes any of my own work, that has been previously, or 
concurrently, submitted for assessment, either at this or any other educational 
institution, including school (see overleaf at 31.2) 
 
 
 
Not sought or used the services of any professional agencies to produce this work  
In addition, I understand that any false claim in respect of this work will result in 
disciplinary action in accordance with University regulations 
 
 
 
DECLARATION: 
I am aware of and understand the University’s policy on plagiarism and I certify that this 
assignment is my own work, except where indicated by referencing, and that I have followed 
the good academic practices noted above 
 
Signed .................................Shehnaz Iqbal...................................................................... 
2  
 
Table of Contents 
(Volume I) 
           Page 
 
Declaration of Originality 1 
 
Table of Contents 2 
 
Acknowledgements 3 
 
Chapter 1. Systematic Review 4 
 
Cancer patients experiences of using decisional support aids: a qualitative systematic review 
 
  Chapter 2. Major Research Project 48 
 
Methodological challenges of developing a tool to measure patient recall and understanding 
from a Haematopoietic Stem Cell Transplantation (HSCT) consultation 
 
Chapter 3. Advanced Clinical Practice I Reflective       92 
Critical Account          
  
“Connecting the dots” - The development of core therapeutic skills: 
 A Reflective Account (abstract only). 
 
Chapter 4. Advanced Clinical Practice II       93 
Reflective Critical Account 
 
The multi-faceted role of the clinical psychologist in the  
Multi-Disciplinary Team (MDT): A Reflective Account (abstract only). 
 
Appendices          94 
    
3  
Acknowledgments 
 
 
I would like to express my deepest thanks to everyone who participated in the making of this 
research. Firstly a huge thank you to everyone who showed interest in the project and in 
particular the patients and consultants who kindly took part, as without them this study would 
not have been possible. I am also grateful to Laura Meehan and Anne Gaffney at the Beatson 
West of Scotland Cancer Centre for their assistance during the recruitment process. I would 
also like to extend my gratitude to the nurses who helped me co-ordinate participant 
interviews amongst the busy clinics. 
 
I am also very grateful to Dr Sarah Wilson for supervising my research. Thank you for all of 
your encouragement, support and guidance over the past three years. I would also like to 
thank Dr Chris Hewitt for providing the necessary practical help and advice. I extend my 
thanks to Professor Andrew Gumley and Professor Pauline Adair for their guidance which has 
gone a long way in shaping the focus of this project. I would also like to say thank you to Dr 
Hamish McLeod for his support and research guidance during the resubmission process. Dr 
Alison Jackson, thank you for all of your suggestions and understanding throughout 
resubmitting. Thank you also to the entire course team, who have been a brilliant source of 
encouragement and good support throughout the doctorate. To my fellow trainees, I am also 
very grateful. 
 
I am thankful to my family and friends for their endless love and support during training. To 
my parents, brothers and sister I am extremely grateful for your faith and confidence in me at 
all times. I am also thankful to my husband Faiz for all of your love, encouragement and 
belief in me during the final stages of my training.  
 
 
 
 
 
 
 
 
 
4  
CHAPTER ONE: 
 
 
Systematic Review 
 
 
 
Cancer patients experiences of using decisional support aids: a 
qualitative systematic review 
 
 
 
 
 
Prepared in accordance with submission guidelines for The European 
Journal of Cancer Care (See Appendix 1.1) 
 
 
 
 
 
 
 
 
 
 
Shehnaz Iqbal 
 
Institute of Health and Wellbeing 
College of Medical, Veterinary and Life Sciences 
University of Glasgow 
Gartnavel Royal Hospital  
1055 Great Western Road Glasgow 
G12 0XH 
5  
 
 
ABSTRACT 
 
This systematic review of qualitative studies investigates how cancer patients utilise 
Decision Aids (DA’s). Meta-ethnography was used to identify and synthesise the 
studies. Articles published until April 2013 were searched in EMBASE, MEDLINE, 
CINAHL and PsychINFO. Relevant journal articles and reference lists were also 
hand-searched. Seven studies were identified for inclusion. Quality was  assessed using a 
rating scale based on Walsh and Downe’s (2006) quality rating framework. Four themes 
were identified: i) Knowledge (ii) Trust (iii) Purpose and (iv)Value. The present review 
highlights that information is gained predominantly from the clinicians involved in the 
patients care and supplemented by the internet to facilitate consultations, to research 
signs of cancer recurring and to validate treatment decisions. Regardless of type, 
information aids perceived as trustworthy and tailored to patient need are most beneficial 
to patients. The findings are discussed and recommendations made in relation to future 
research and how health care professionals can develop and incorporate DA use in clinical 
practice. 
 
Keywords: Qualitative systematic review, lived experience, decision aid, cancer, quality of 
life. 
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INTRODUCTION 
 
Improving the delivery of medical information for patients is an important element of 
Scottish health care policy. In order to achieve this, consideration has been given to 
understanding the experiences of those with cancer throughout the journey of their 
illness. Healthcare policies in the United Kingdom (UK): “NHS Scotland Quality 
Strategy - Putting People at the Heart of Our NHS” (Scottish Executive, 2010) and 
“Excellence and Equality: Liberating the NHS” (Department of Health, 2010) emphasise 
the need for modern cancer services to be designed in a patient centered way. 
Therefore, the needs, preferences and experiences of cancer patients ought to be central to 
any discussion, particularly in the context of introducing novel technologies and designing 
services (Ring et al. 2011). 
 
There is a growing body of evidence indicating that more patients’ wish to be actively 
involved in their treatment decision-making in a way which can take into 
consideration their personal values and preferences (O’Brien et al. 2009). More formally, 
this is known as “shared decision-making”. This is an approach which lays emphasis on 
the patients as experts on their own health and treatment preferences, as well as on the 
need for communication and explanation regarding medical conditions and treatment 
being provided accurately and sensitively (Neuman et al. 2007). Shared decision-
making can have vast implications for cancer patients and healthcare professionals and 
in relation to related healthcare outcomes such as, adherence to treatment, coping with 
the illness itself and overall quality of life (van der Meulen et al. 2007). 
 
Typically, patients attend a medical consultation during which they are provided with 
information about the disease itself and treatment alternatives. The provision of such vital 
information is to help patients prepare for treatment but it can also cause patients 
confusion, anxiety and uncertainty where treatment options exist. Despite policy and 
empirical research suggesting positive benefits from patients being involved in their own 
care, perhaps surprisingly, the literature also reflects that not all people with various 
forms of cancer wish to participate in treatment decisions (Balmer, 2002). This suggests 
that a balanced, more accurate representation of the informational needs and unique illness 
experiences of cancer patients is necessary. 
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Background 
 
 
The existing literature reflects Ley’s seminal work (1988) in relation to understanding 
effective communication. This model conceptualises the relationship between memory, 
understanding and satisfaction as being central to a patient’s adherence to treatment and 
their ability to recall information. It is estimated that 40% to 80% of medical information 
presented by health care professionals was forgotten immediately by patients; this was 
influenced by a combination of consultant (i.e. use of medical terminology) and patient 
factors (i.e. emotional state and older age) (Kessels, 2003). Similarly, the communication 
style of the consultant, as well as a patient’s cognitive processes and anxiety are additional 
factors which have been shown to have an impact upon the patient’s recollection and 
comprehension of medical information. Collectively, these factors may create 
emotionally distressing and challenging situations for patients. Consequently, in response, 
mechanisms of support have been developed and are available to assist patients during the 
management of their disease. 
 
Decision/information Aid use in the cancer setting 
 
The most commonly cited form of support used to enhance the transfer of information 
between health care providers and patients, and some aspect of decision-making, is the 
clinical decision/information aid (DA/DAs). The DA has shown to be effective across 
various clinical settings, including cancer (Watson and McKinstry, 2009). The 
information in a decision aid is typically presented visually, although the format may vary. 
In simplest form, a decision aid may be a pamphlet or additional information sought by 
the patient from within the multi-disciplinary team (MDT). There are other, more definitive, 
forms of decisional support- aids, including, interactive computer programmes, decision 
boards, videotaped interventions, consultation audiotape/CD, internet websites, 
structured interviews and nurse navigators. The cancer patient can also access support 
and medical information from other sources such as the internet, family members and 
friends (Rozmovits and Ziebland, 2004). 
 
Typically, DAs are used as adjuncts to the clinical consultation to encourage a balanced 
encounter and to enhance the processing of potentially distressing medical information 
otherwise deemed difficult to take on board by patients (Thorne et al. 2005). Broadly 
speaking, the aim of using DAs is to enhance patient decision-making and involvement and 
thereby develop better relationships between healthcare providers and patients (Neuman 
et al. 2007, O’Brien et al. 2009). 
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Whilst it is beyond the scope of the present review to provide a detailed outline of 
varying definitions and description of DA use among the cancer population, the 
following quote captures the essence of DA use in clinical reality: 
 
“‘An intervention designed primarily to help patients (or patients and clinicians 
together) with making cancer-related health care decisions when options were available 
for screening, prevention and treatment, anxiety, decisional conflict, patient satisfaction 
and role in decision making”. (p.975) 
(O’Brien et al. 2009). 
Consistent with O’Brien et al. (2009), Neuman and colleagues (2007) propose that, by 
describing the associated medical and psychological issues, decision aids facilitate 
patient-driven decision-making based upon patients’ values and preferences. In view of 
the policy and empirical support for decision aid use in the clinical setting, the 
remainder of this review will briefly examine the evidence-base in relation to definitive 
decisional (e.g. specific interventions designed to facilitate decision making) and other 
informational supports (e.g. internet, media) in one particular context; the use of decisional 
support aids amongst people with cancer. 
 
 
Evidence base for the impact of DA use among the cancer population 
 
Over the past 20 years, there has been a proliferation in research on the use of 
resources to facilitate communication between the doctor and patient in the cancer 
setting. This is dominated by research investigating patient outcomes, from a clinical 
perspective using quantitative methodology. Quantitative studies typically evaluate the 
use of DAs in relation to decision making about treatment and the impact DA use has on 
patient anxiety and knowledge about disease and treatment. These studies provide a 
valuable foundation from which to explore and understand outcomes related to decision 
making. O’Brien et al. (2009) performed a quantitative systematic review and meta-analysis 
in the cancer screening, treatment and prevention setting evaluating the use of DAs on two 
levels: 
1. In usual practice. 
2. In the clinical utility of one type of DA over another based on the following 
outcome measures: “patient knowledge”, “patient anxiety”, “role in decision 
making” and “decisional conflict”. 
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The review and meta-analysis included 34 randomised controlled trials (RCTs) and 
compared DA use with a ‘wait list’ control group, usual practice or with another type of 
decision aid. Two independent reviewers using established criteria; a combination of the 
Jadad Scale (Jadad et al. 1996) and Downs and Black Scale (Downs and Black, 1998) 
assessed the methodological quality. In line with earlier quantitative reviews of RCTs (e.g. 
Neuman et al. 2007) O’Brien et al. (2009) concluded that use of DA’s reduced patient 
anxiety, enhanced patient knowledge and decision making in comparison to usual 
practice, particularly in the screening context. They also found that there were too few 
comparative studies to determine which type of DA was most helpful. 
 
Similarly, a more recent meta-analysis performed by Spiegle et al. (2013) also compared 
different types of DAs. They included 24 RCTs for review, assessed using the criteria set 
out by the Cochrane Collaboration and found that there were no significant 
differences in knowledge, satisfaction, anxiety or decisional conflict scores between patient 
DAs and alternative forms of decisional support systems. Therefore, these findings 
suggest that less complex non-specific supportive interventions such as pamphlets maybe 
all that are necessary to achieve similar outcomes (e.g. reduced anxiety, enhanced 
decision-making and patient satisfaction) for cancer patients. 
 
An earlier review by Neuman et al. (2007) discussed the theoretical aspects of decision-
making contributing to the development of cancer related decision aids and testing their 
efficacy. The authors also provided a narrative review of RCTs evaluating cancer-
related decision aids. They reported that DAs are beneficial in conveying knowledge 
about treatment, screening and prevention. However, the efficacy of DAs, specifically in 
facilitating treatment decision making, was less clear. 
 
As identified by the Centre for Reviews and Dissemination (2014), there are several 
methodological flaws inherent in the earlier studies that prompt one to question the 
reliability of the results. For example, although O’Brien et al. (2009) searched relevant 
databases for articles, they did not report on any search terms and how they performed 
data extraction. Consideration was neither given to unpublished studies or to publication 
bias. Spiegle et al. (2013) and O’Brien et al. (2009) reported that generally the 
methodological quality and level of heterogeneity for RCTs included for review was poor. 
 
Several methods have been shown to be effective for improving a patient’s absorption of 
medical information, including the use of information leaflets and interactive computer 
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programmes. Systematic evaluation of quantitative research has concluded that DAs, 
when provided, are clinically beneficial in enhancing patient knowledge about 
treatment, setting realistic patient expectations and overall patient satisfaction in relation 
to those who experience breast, prostate, lung and colorectal cancer (van der Meulen et al. 
2008; Neuman et al. 2007, Lin et al. 2009, O’Brien et al. 2009; Spiegle et al. 2013). It is 
therefore clear that, although useful, DAs are created with the guidance of medical 
professionals rather than patients and as such, these outcome measures do not reflect 
the reality of what people with cancer experience when using DAs. 
 
 
Clearly, other factors influence how a person with cancer responds to being given 
medical information. For example, when a patient has been given information about 
treatment options and associated side effects their level of anxiety may, understandably, 
become increased rather than decreased (O’Brien et al. 2009). People with cancer may have 
an alternative set of outcomes that are perceived to be just as, if not more, relevant than the 
outcomes defined by studies of quantitative research (Neuman et al. 2007). This approach 
also neglects the fact that cancer patients also use, or may indeed be influenced by, 
sources of information such as the internet or family members to understand aspects of 
their disease and treatment. 
 
 
From a patient’s point of view, qualitative studies have proven more useful in exploring 
how and the type of sources cancer patients use to meet their changing information 
needs as they experience their illness (Dickerson et al. 2011). In doing so the type of 
sources and the informational needs of cancer patients can be better understood and 
thus provide a valuable contribution to our understanding of how DAs and other resources 
are used thus allowing clinical implications for policy and service design to be considered. 
 
 
Rationale for systematic review 
 
There are several methodological challenges of quantitative methods when measuring 
patient use of information aids in the cancer setting. Firstly, the appropriateness of 
decision making outcomes including; patient satisfaction, knowledge, decisional conflict, 
and anxiety have been questioned and there is no consensus, to date, on the most adequate 
instruments with which to measure these domains (Neuman et al. 2007, O’Brien et al. 2009, 
Lin et al. 2009). Where patient acceptability of DAs has been evaluated this has been 
through the objective measurement of appointment duration (Lin et al. 2009). Recent 
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evidence suggests that there is no difference between the use of DAs and other supportive 
interventions to patient outcome (Spiegle et al. 2013). This suggests that different 
information aids, aimed at improving treatment decision- making may, have equal bearing 
on the aforementioned outcome measures. 
 
Reviews of quantitative evidence, which primarily aim to determine the effectiveness of 
interventions, lack exploration of the patients’ perspective. Whilst attempts have been 
made to provide narrative synthesis (e.g. Neuman et al. 2007, O’Brien et al. 2009), 
there are currently no reviews that systematically integrate the findings from the 
available qualitative literature on how patients with cancer use DAs. Qualitative methods 
may add greater breadth and depth by focusing on the personal experiences of those 
patients’ who use information aids (Ring et al. 2011). In doing so, reviews of qualitative 
studies may more accurately reflect patients’ experience and inform future service design 
and implementation of DA interventions in clinical practice. 
 
As discussed, the results from clinical outcome studies provide extensive evidence that 
DAs can improve knowledge in cancer people with cancer. However, there remains a lack 
of understanding about cancer patients’ information needs in the cancer context and how 
this population attempt to meet their needs through the use of DAs. Given this gap in 
knowledge, the past few years has seen the emergence of qualitative research which 
has investigated cancer patients’ perspectives on the use of hospital produced DAs and 
how cancer patients access sources of information outside of this environment (Lacey 
2002, Dickerson et al. 2006; 2011, Thygesen 2011; 2012, Balmer 2005, Rozmovits and 
Ziebland, 2004). There is a need to systematically integrate these findings and develop a 
more consistent understanding of the topic. Neglecting to do so may result in the failure to 
gain a deep understanding of patient perspectives and limit our role as reflective 
researchers. 
 
Neuman et al. (2007), Lin et al. (2009), O’Brien et al. (2009), and Spiegle et al. 
(2013) have already performed quantitative systematic reviews and meta-analyses 
evaluating the effectiveness of cancer related DAs in relation to patient anxiety, patient 
knowledge, decision making and satisfaction. The scope of these earlier reviews is too 
wide for the present proposed synthesis. This synthesis therefore will aim to add 
descriptive value to this existing literature by providing an experiential, instinctive 
enhanced understanding of DA use and explain the diverse results from the aforementioned 
reviews that will have potentially significant practical implications for transforming 
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future clinical, research and service developments (Noyes and Popay, 2002). 
 
To the author’s knowledge, no previous qualitative systematic review has been conducted 
relating to patients’ experiences of DA use in the cancer setting. The aim of this 
systematic review is to explore a specific aspect of cancer patients’ experience, that is their 
reflections on using DAs, to see if their experiences could inform clinicians and policy-
makers decision making about the implementation of DAs in clinical practice. 
Decisional support aids are defined as non ‘face to face’ resources (e.g. written 
notes/diagrams, pamphlets, audio tapes, videos, internet) and face to face encounters (e.g. 
nurses, doctors, other members of the MDT, nurse navigators, and involvement of family 
and friends). 
 
Review Question 
 
How do people with cancer make use of DAs to meet their informational needs? 
 
 
Review objective 
 
 
The objectives of this review are: 
1. To use meta-ethnography to explore the extent and manner in which cancer 
patients use decisional support aids, at all stages of diagnosis, treatment and 
survivorship; 
 
2. To methodologically assess the quality of relevant studies and describe key 
findings of the qualitative literature in this area; 
 
3. To identify, synthesise and interpret emergent themes from the identified 
studies and to discuss the implications of these results by performing a 
systematic review of relevant published studies. 
 
METHODS 
 
Method of search strategy 
 
The EBSCO host was used to search CINAHL, PsychINFO and SocINDEX, and OVID 
was used to search Medline and Embase databases. The Cochrane Library and Web of 
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Science were also searched. All searches were completed on 12 April 2013 using the 
search terms below including the Boolean operator terms “AND” and “OR”. 
 
Search terms 
 
The identified search terms were collated from two papers: O’Brien et al. (2009) and van 
der Meulen et al. (2008), who conducted quantitative meta-analyses of interventions 
used in the clinical setting to improve recall of medical information in cancer patients. 
The current systematic review incorporates search terms used by O’Brien et al. (2009) 
and van der Meulen et al. (2008) as well as those identified following an initial key 
word search which yielded 479 papers. The abstracts and titles of these were searched and 
further search terms were used, in addition to the original search items, with a specific 
focus on qualitative research. 
 
1. Cancer or cancer* or cancer* or oncolog* or neoplas* or tumo?r* or sarcoma* or 
leuk?emia* 
 
2. patient* or client* or (service adj user*) or inpatient* or outpatient* or sufferer* or 
victim* or survivor* 
 
3. memor* or remember* or recall* or retention or recollection or understand* or 
comprehension* or cognition* or attitude* or decision* 
 
4. intervention* or recording* or leaflet* or aid* or communication* or handout* or 
(prompt adj sheet*) or education* or coaching* or CD* or DVD* or participat* or 
multi-media* or mp3* or illustration* or pamphlet* or internet or support* or 
technique* or information* 
 
5. qualitative research 
 
6. 1 AND 2 AND 3 AND 4 AND 5 
 
Studies identified in the electronic search were compared to the inclusion and exclusion 
criteria in a three-step process: comparing against study title, abstract and full text 
(Noblit and Hare, 1988). A total of seven studies were identified by the search (see 
Figure 2 for flowchart of search results and Figure 3 for study details). 
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Inclusion criteria 
 
 
This review included: 
 Studies that recruited participants diagnosed with cancer; 
 Studies investigating the experience or perception of a decision or information aid 
on decision making about treatments; 
 Studies that collected data from outpatient clinics; 
 Qualitative studies only (e.g. using ethnographic, naturalistic, interpretive, 
grounded, phenomenological, subjective, or participant observational principles) 
 Publications up to and including 12th April 2013 
 
Exclusion criteria 
 
 
The review excluded: 
 Studies that evaluate the experiences of medical professionals and/or cancer 
patients and their family members; 
 Studies that focussed exclusively on the technicalities of the DA; 
 Studies that were not published in English; 
 Case studies; 
 Studies that collected data from people with a focus on pre-existing 
communication difficulties (e.g. individuals for whom English was not their first 
language and those with a learning disability/difficulty); 
 Studies that did not capture patient experiences in qualitative form (e.g. used 
quantitative outcome measures); 
 Quantitative or mixed method studies; 
 Research oriented toward local  quality-improvement initiatives  rather than 
scientific research, evaluation, and publication; 
 Book chapters. 
  
Method of quality assessment 
 
 
There exists considerable debate about the use of assessment criteria to appraise qualitative 
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research. Unlike the appraisal of quantitative studies, there is little consensus as to the 
essential criteria for a high quality qualitative study, leading to the development of over 100 
quality appraisal tools (Pope et al. 2007). Despite this, many researchers acknowledge the 
requirement for well-defined approaches for assessing the quality of research (Pope et al. 
2007) and a number of different tools and techniques are now available. The use of quality 
assessment is further complicated by debate concerning when it should be performed. The 
need for appraisal of studies before the synthesis has been queried (Pope, 2003). For the 
present review, however, the appraisal process provided a useful introduction because it 
helped to narrow down studies that did not meet inclusion criteria and develop an overall 
profile of strengths and weaknesses of each research paper included. 
 
Walsh and Downe (2005) developed a practical guide for assessing the quality of qualitative 
studies, having reviewed eight previous frameworks for qualitative research. Quality of 
assessment consisted of 29 items divided between eight essential criteria (i.e. scope and 
purpose; design; sampling strategy; analysis; interpretation; reflexivity; ethical dimensions; 
relevance and transferability). Studies were awarded a score of ‘1’ if the criterion was present 
and ‘0’ if the criterion was absent or if it was not possible to determine a profile of strengths 
and weaknesses from information given. This framework was used to identify the quality 
of the studies rather than to exclude those failing to meet a predetermined criterion. Whilst 
this may be considered a weakness of the chosen methods, meta-ethnography approaches 
take the view that quality should not be a criterion used to exclude studies, and ought to 
be given consideration in the descriptive analysis of each study (Sandelowski et al. 2004). 
To enhance the validity and transparency of the review, all studies were independently 
analysed by another researcher using the same quality rating scale (Appendix 1.2) and any 
disagreements were resolved through discussion. Agreement on each of the individual item 
scores between the 2 raters reached 100%.  
 
Method of synthesis 
 
Synthesising qualitative research is a complex task. There are many ways of synthesising 
themes and accounts from studies using qualitative methods including, but not confined to, 
meta-ethnography, grounded formal theory, cross case analysis and meta-study (Pope et al. 
2007). Use of such methods is complicated by the fact that there is no single agreed approach. 
Contrary to quantitative meta-analysis, qualitative meta-synthesis is not about averaging or 
reducing findings, but rather enlarging the interpretive possibilities, allowing higher order 
interpretations or general theories to emerge (Sandelowski et al. 2007).  
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Meta-ethnography was chosen for this review as it was deemed most appropriate for the 
proposed research question; to obtain new insight and meaning into the use of decisional 
support aids by cancer patients which have been identified as effective in improving patient 
knowledge, reducing decisional conflict about available treatments and overall satisfaction by 
previous reviews and meta-analyses of quantitative research. This approach also allows for 
the synthesis of research studies that draw upon a variety of qualitative research methods and 
permits the transformation of individual studies as an expression of each other’s terms. This 
enables direct comparison of qualitative accounts from studies as opposed to seeking solely 
the degree of commonality among themes (comparative case study) or facilitating reduction 
of categories (grounded theory) to generate new theories/ideas (Pope et al. 2007). Noblit and 
Hare (1988) and Atkins et al. (2008) outline seven stages for meta-ethnography (Figure 1). 
This synthesis will follow these key steps in order to select, critically appraise and synthesise 
qualitative research studies. The study themes and quality ratings of each paper are outlined in 
the results section in Figure 3. The researcher has attempted to share as much of their data 
analysis procedures to enhance the validity of their work by using the analysis framework 
by Noblit and Hare (1998) and guidelines set out by Britten et al. (2002).
  
 Figure 1. Seven stages of meta-ethnography (redrawn from Noblit and Hare, 1988) 
 
 
Step Stage Description of each stage 
Step 1 Getting started Develop a research question 
 
Step 2 
 
Deciding what is relevant for initial interest Define focus of synthesis /Locate relevant studies /  Make decisions 
on inclusion criteria / Carry out a quality assessment 
Step 3 Read the studies Become familiar with the detail and content of the studies 
Extract metaphors and emerging themes 
 
Step 4 
 
Determine how the studies are related 
 
Create a list of themes and metaphors / Juxtaposition of themes 
Determine how the themes are related / Reduce themes into categories 
 
Step 5 
 
Translate studies into one another 
 
Arrange each study into chronological order / Compare themes from paper 1 
with paper 2 and the synthesis of these two papers with paper 3 and so on 
 
Step 6 
 
Synthesising translations 
 
Higher order interpretation to provide a line of argument synthesis 
 
Step 7 
 
Expressing the synthesis Discussion and write-up of the results 
Publication 
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RESULTS  
 
 
Results of search strategy 
 
 
The database search yielded 4866 citations, of which, 872 articles were discarded as they 
were duplicates. The titles of the remaining 3796 were scanned for relevance to the topic. 
From the title, 234 articles were deemed suitable. Subsequently, the abstracts of these 
articles were examined, using the inclusion criteria, resulting in the exclusion of a further 
223 articles. This left 11 potentially appropriate articles, of which 4 were excluded after 
reviewing the full text. The reasons were (Appendix 1.1); patients were at risk of breast 
cancer but had received no diagnosis (Iredale et al. 2008), English was not the first 
language for one person in the sample (Korber et al. 2011), another study was an 
abstract/poster for a conference (Shephard et al. 2012). A further study was excluded 
because it included the views of health professionals as well as patients (McJannet et al. 
2003). The reference lists from all included articles were searched manually to ensure the 
sensitivity of the search, as electronic searches may not identify all relevant qualitative 
studies (Walsh and Downe, 2005). The same 3-step search mentioned above was performed 
and did not reveal any further articles that met inclusion criteria. A flow chart detailing this 
process is provided in Figure 2.  
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Figure 2. Flow chart of search results 
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Figure 3: Completed grid methods and concepts 
 
Study Balmer (2005) Dickerson et al 
(2011) 
Dickerson et al 
(2006) 
Lacey (2002) Rozmovits & 
Ziebland (2004) 
* Thygesen et al. 
(2011) 
* Thygesen et al. 
(2012) 
Rating 20/29 = 70% 25/29 = 86% 27/29= 93% 27/29 = 93% 18/29 = 62% 22/29 = 75% 25/29 = 86% 
Type of 
support 
All types of 
media 
Internet Internet Decisional 
support aid 
through nurse 
DipEx 
(interactive 
website) 
Nurse navigator 
(NN) 
NN 
Sample 15 (4 males & 11 
females) 
Aged 43-75 
Diagnosed with 
cancer 
Completed first 
line treatment 
15 males 
All diagnosed 
with prostate 
cancer 
Aged 47-78 
20 patients 
All female 
Mean age 52 
Variety of 
cancer 
diagnoses & 
stages 
12 women 
Diagnosed and 
treated for breast 
cancer 
Disease free 
8 males/females 
Diagnosed with 
breast or 
prostate cancer 
Age 39-75 
5 women 
Diagnosed with 
cancer about to 
undergo surgery 
Aged 37-76 
11 women 
Diagnosed with 
cancer about to 
undergo surgery 
Aged 32-79 
Data collection Lincoln &Guba’s 
naturalistic 
enquiry 
Hermenuetic 
analysis 
Phenomenology 
(Colazzi’s 
method) 
Thematic 
methods 
Phenomenologic 
al hermeneutical 
Phenomenology 
and hermeneutics 
Phenomenology 
and hermeneutics 
Setting Community 
setting, United 
Kingdom 
Community, 
support group, 
north eastern 
United states 
Outpatient 
setting, 1 to 1, 
north eastern 
United States 
Home, 1 to 1, 
North Eastern 
America 
Outpatient 
setting, focus 
group, UK 
Outpatient setting, 
Denmark 
Outpatient 
setting, Denmark 
* Thygesen et al. (2011) was part of a larger study Theygesen et al. (2012) 
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Figure 3. Continued: completed grid methods and concepts 
 
Knowledge Positive and 
negative health 
care professional 
experiences 
Feelings of 
mistrust with 
current 
physician 
Personal coping 
style 
Finding nurses 
were 
unavailable or 
uninvolved in 
initial stages 
Consultants not 
regarded as best 
sources of 
information 
Individuals whom 
felt they could use 
help from NN or 
bad experiences 
with health 
professionals 
Individuals who 
felt they could use 
help from NN or 
bad experiences 
with health 
professionals 
Trust Some media 
sources more 
credible than 
others. Internet 
most trustworthy 
and informative 
source outside 
hospital 
environment. 
Concerns about 
credibility of 
internet 
information. 
Information 
sought 
confirmed with 
more sites or 
consultation 
with support 
networks/person 
with medical 
knowledge 
Trusting opinion 
& advice of 
physicians about 
treatment 
decisions 
- The NN was 
experienced as 
trustworthy & 
forthcoming, who 
helped them over 
time 
NN experienced 
as trustworthy, 
experienced and 
credible& 
culturally 
sensitive 
Purpose “Technical stuff” 
“Up & coming 
treatments” 
“Life stuff” 
“Other people’s 
stories” 
- Retrieving and 
filtering 
information 
according to 
personal 
situation and 
diagnosis 
- Available 24 
hours per day. 
Approachable. 
Benefiting from 
experiences of 
others without 
emotional 
demand. 
Patients felt 
reassured to know 
they had the same 
contact over time 
- 
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Value Contributed to 
decision making 
about treatment, 
information about 
coping 
More 
knowledgeable 
about treatment 
and proactive. 
Enhanced sense 
of control and 
problem solving 
ability 
Enhance 
decision making 
about treatment. 
Provides peace 
of mind and 
hope.  Self- 
management 
and validation of 
treatment 
options. 
Maintaining 
hope/managing 
fear. 
Nurses support 
through 
decisional 
support deemed 
most helpful 
Allows 
triangulation of 
information 
from other 
websites and 
physicians. 
Sense of peer 
support 
Supplement to 
loved ones in a 
period with 
insecurity and 
vulnerability. 
Stable contact with 
professional 
knowledge and 
skills. Increased 
sense of control 
and reduced 
anxiety. Enhanced 
emotional support 
Enhanced 
knowledge about 
disease, treatment 
and psychosocial 
support 
Conclusions/the 
ories 
Media was used 
throughout the 
experience of 
living with 
cancer. This was 
viewed as a major 
contributor 
towards decision 
making about 
treatment 
Patients 
selectively used 
internet 
information to 
facilitate 
provider 
encounters, 
monitor 
reoccurrence, 
make decisions 
about treatment 
and cope with 
and manage 
fears. 
Internet used to 
understand 
illness, manage 
expectations 
about coping 
and verify 
treatment 
decisions. 
“Hearing others 
stories of 
survival helped 
patients manage 
fears and 
maintain hope” 
“ Healthcare 
providers, 
particularly 
nurses, are vital 
and either 
positively or 
negatively 
viewed”. 
Decision- 
making process 
is complex & 
can cause 
psychological 
burden. 
Patient 
demographic 
profile may 
influence 
information 
seeking. 
Websites 
suggested/devel 
oped by 
healthcare staff 
perceived as 
more credible 
than commercial 
websites. 
Nurse navigators 
viewed as secure 
base, reliable, 
knowledgeable and 
supportive 
throughout disease 
trajectory. 
Healthcare staff 
ought to be 
sensitive to endings 
in context of being 
viewed as 
attachment figures. 
“Trust or lack of 
the same in health 
care 
professionals/syst 
em influenced 
how patients 
related to the 
Nurse navigator” 
Lack of close 
family support, 
culturally 
sensitive 
approach may 
also influence NN 
use. 
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Results of quality appraisal 
 
 
Scope and purpose 
 
The scope and purpose of each study was described with clarity in most studies with 
researchers making a clear statement of focus for research being, predominantly, to evaluate 
the lived experiences of cancer patients’ who use decision support aids to meet their 
informational needs. All studies reviewed also demonstrated good sensitivity to context 
through description of the rationale, aims and review of existing literature in relation to the 
aims of the individual studies (Lacey 2002, Dickerson et al. 2006; 2011, Thygesen 2011; 
2012, Balmer 2005, Rozmovits and Ziebland, 2004). 
 
Design 
 
The design/method of all studies was reported and consistent with the research intent. 
Three studies demonstrated sensitivity to the epistemological grounding in relation to the 
rationale for the specific qualitative method used (Balmer, 2005; Dickerson et al. 2006; 
2011). Dickerson et al. (2006; 2011) demonstrated particular strength in this area. All 
researchers provided a description of their method of data collection; either semi-
structured interview or focus group and the data collection strategy was apparent and 
appropriate for all seven studies. Most studies described use of open-ended questions 
during semi-structured interviews and demonstrated sensitivity to the social/physical and 
cultural context of data collection (Thygesen et al. 2012; Lacey, 2002; Dickerson et al. 
2006; 2011, Balmer 2005). 
 
Sampling strategy 
 
In terms of sampling strategy, all studies used either consecutive, purposive or 
convenience sampling as their recruitment method appropriate for the aims of the 
research. Two studies did not give information about non-participation, specifically 
declining to take part (Rozmovits and Ziebland 2004; Balmer, 2005). The other studies 
reported reasons for declining participation and dropout (Dickerson et al. 2006; 2011; 
Thygesen et al. 2011; 2012; Lacey 2002). All studies supplemented this information by 
providing demographic characteristics of the sample adding to the thickness of description, 
with one study in particular specifically stating this in the main body of the paper 
(Thygesen et al. 2012). Thygesen et al. (2011) reported being part of a larger study 
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(Thygesen et al. 2012). It was unclear from the studies if the samples overlapped. 
 
Analysis 
 
 
All but one of the studies (Rozmovits and Ziebland, 2004) were explicit about their 
data analysis methods which included different types of qualitative methods; Collaizzis 
method, a Phenomenological Hermeneutical approach, a n d  constant comparison. Two 
studies combined the latter approach with Ricoeur’s theory of interpretation (Thygesen 
et al. 2011; 2012). The majority provided detailed descriptions of the qualitative methods 
used (Dickerson et al. 2006; 2011, Lacey 2002, and Thygesen et al. 2011), demonstrated 
commitment to the chosen research method through descriptions of data collection, 
analysis and validation of emerging themes by emailing participants for clarification 
and agreement about resultant themes (Dickerson et al. 2006; 2011). These studies 
also reported that data collection continued until the point of saturation (Dickerson et al. 
2006; 2011). Two studies described using method triangulation such as diaries and 
observational information combined with participant interviews (Thygesen et al. 2011; 
2012) adding credibility and validity to the analysis process. Lacey (2002) was the only 
study that reported auditability and provided a description of a decision trail. This was a 
reflection of the level of variation across the studies within this particular domain. A 
second researcher was involved in data interpretation in most studies (Rozmovits and 
Ziebland 2004; Dickerson et al. 2006; 2011; Lacey, 2002). In the absence of a second 
researcher, however, two papers mentioned that discussions took place with other 
researchers at various points during data analysis (Thygesen et al. 2012; Balmer, 2005). 
 
Interpretation 
 
The context was described and taken into account as all researchers described use of 
a specific decision support aid (nurse navigator, internet use, specific website, and family 
member who was medical professional) in the context of the cancer patients’ illness. All 
of the researchers used interview data to support their interpretations. Rozmovits and 
Ziebland (2004) and Balmer (2005) were the only two studies that did not explicitly 
report detailed data analysis, specifically that time was spent dwelling with the data, 
interrogating it for competing/alternative explanations of phenomena, how agreement on 
themes were reached and conflicts resolved. 
  
Reflexivity 
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All but one of the studies (Rozmovits and Ziebland, 2004) demonstrated researcher 
reflexivity to some extent, reported through description of the analysis process. 
However, only two studies explicitly reported on “interviewer effects” (Balmer 2005), 
and the relationship between researcher and participants during fieldwork (Lacey, 2002). 
 
Ethical dimensions 
 
 
References to ethical dimensions in each study varied. This was a further limitation 
of Balmer (2005) and Rozmovits and Zibland (2004) as they did not report on any of the 
ethical dimensions. Lacey (2006) and Dickerson et al. (2011) only made reference to 
how documentation was managed and did not indicate whether ethical approval had been 
granted or indeed how confidentiality and anonymity were managed. On the other hand, 
Thygesen et al. (2011; 2012) and Dickerson et al. (2006) demonstrated sensitivity in all 
aspects of ethical concerns, including ethical approval, evidencing their dealings with 
participants, resolving dilemmas and confidentiality and explaining how it was maintained. 
 
Relevance and transferability 
 
Finally, all studies provided a varied amount of evidence of the relevance and 
transferability of findings. Although Dickerson et al. (2011) and Rozmovits and 
Ziebland (2004) made reference to theories/literature and outlined directions for research, 
they did not report limitations/weaknesses of their research studies. Similarly, Balmer 
(2005) and Thygesen et al. (2011) did not outline any directions for further research. 
 
Results of synthesis 
A list of concepts and themes from each of the studies included in this review are displayed in 
Figure 3. During the stages of meta-ethnography the relationships between themes arising 
from the different studies were considered. Four overarching concepts emerged across the 
papers included for synthesis: (i) Knowledge (ii) Trust (iii) Purpose and (iv) Value. 
 
To be explicit about how the themes compared with one another, a visual data display was 
created to recognise similarities and differences that shaped findings among studies (see row 
labels in Figure 2). The first four rows of the grid include relevant details of the study 
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setting and research design. These methodological details are essential contextual 
information for the synthesis. From the sixth row onwards, each row of the grid 
represents a key theme. The conclusions in the last row are explanations and theories (Miles 
and Huberman, 1994). 
 
Second-order interpretations arising from each paper were also established. As a way of 
preserving the originality in each study, the terms used in the original papers are retained in 
the grid. Those in quotation marks use the original author(s)’ own words; those not in 
quotation marks are based on the researcher’s paraphrasing of the original papers. The grid, 
therefore, indicates how each theme is encompassed within each study. 
 
Synthesising translations 
 
The themes and associated interpretations were considered from the grid and it was possible 
to establish how the concepts proposed in one study could be expressed in relation to those 
used in another study. This involved the use of ‘reciprocal translation’ that explored themes 
and concepts of individual studies in relation to one another, attached meanings, and drew 
inferences from the relationships found between studies. 
 
The use of a matrix (Figure 2) and chart (Figure 3) facilitated systematic comparisons by 
exploring the themes and identifying common concepts. In order to explore how cancer 
patients used DAs the concepts of each study were compared one by one with the key theme 
to establish the extent to which they were similar or different. 
 
In each study the conclusions were identified and highlighted as 
explanations/interpretations/theories and these findings and themes were then compared with 
one another within and across studies. This process represented elements of the “line of 
argument synthesis” component of meta-ethnography, establishing whole themes “amongst a 
set of parts” (Noblit and Hare, 1988). Four third-order interpretations were formed (Figure 4). 
 
Figure 4: second and third order interpretations 
 
 
 
Themes Second order 
Interpretations 
Third order interpretations 
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Knowledge Feelings of fear and perceived 
lack of contact triggered the 
search for information beyond 
the health setting. 
If healthcare  providers 
provide psychosocial support 
from onset, then this would 
enhance attachment, and faith 
in healthcare professionals 
expertise and reduce patients 
anxiety 
Trust Some media sources more 
credible than others. Internet 
most trustworthy and 
informative source outside 
hospital environment. 
Trustworthy information is 
defined by cultural sensitivity, 
accuracy, and information 
tailored to patient need 
delivered verbally and/or 
electronically 
Purpose Patients selectively used 
internet information to, 
facilitate provider encounters, 
monitor reoccurrence, make 
decisions about treatment, 
cope with and manage fears. 
If delivered in this way, 
information          can          be 
empowering, allowing 
patients to be active members 
of their treatment throughout 
the trajectory of their illness 
Value Enhanced decision making 
about disease, treatment, 
quality of life and 
psychosocial support. 
Patients experience an 
enhanced sense of control, 
reduced vulnerability and 
perhaps improved healthcare, 
adherence to treatment and 
quality of life. 
 
 
Summary of themes from the studies reviewed 
 
As Miles and Huberman (1994) propose, line of argument is established through the 
consideration of each theme and second-order interpretation subsequently. The line of 
argument, which constitutes the synthesis achieved in this review, is as follows: 
 
There are two types of information sources patients’ use: ‘face-to-face’ contact (e.g. 
with health care professional) and non ‘face-to-face’ contact (e.g. the internet). The 
use of a decision aid is an example of a patients’ need to be proactive and involved in 
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aspects of his or her healthcare, illness and treatment. The search for information about 
cancer is predominantly precipitated by the following events: negative interactions with 
healthcare professionals, lack of support from within existing network of friends and 
family to crosscheck information given by healthcare professionals and to seek support 
from other cancer patients. For others a real avoidance of any information related to 
their illness was apparent as they expressed their shock, uncertainty and fears following 
diagnosis. 
 
Patients may have felt overwhelmed by the complexity and emotional impact of their 
illness or the information they received. Individuals may not have taken on board 
information perceived not to be medically legitimate or reported “switching off” if this 
occurred, thus inhibiting their ability to understand medical information. From the media, 
the internet was deemed the most up to date and credible source. However, t h e  patient 
viewed commercial websites with caution. Information gleaned from the internet was 
filtered and verified with physicians. Where nurse navigators were used as trusted 
information aids, they were perceived as close attachment figures. Thus if the patient 
trusted the source of information they tended to take it on board. 
 
Communication between healthcare providers and cancer patients can be improved if there 
is trust. Trust is established to the extent to which each source is deemed credible, 
valid, consistent, culturally sensitive and available from the onset. Lack of trust can give 
rise to feelings of fear and vulnerability contributing to poor decision making about 
treatment, symptom management, coping and management of quality of life issues. Using 
‘face to face’ and non ‘face to face’ information aids, cancer patients can ultimately benefit 
from the stories of other cancer survivors’ sense of empowerment, problem-solving and 
peer support. This can in turn facilitate encounters with health care professionals and, 
in particular, validate treatment recommendations. 
 
Detailed quotations related to the themes identified are now described. The process of 
synthesis drew out the following four key themes for patients using an information aid (i) 
Knowledge (ii) Trust (iii) Purpose and (iv) Value. By categorising the most prominent 
elements identified in the synthesis, each theme will be discussed in turn. Quotations 
from study participants appear in italics, quotations from the authors of the studies do not. 
 
Knowledge 
 
All studies indicated that a patient’s information needs were complex and changed over 
time. Patients reported either feeling “shocked” or “overwhelmed” at diagnosis and 
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this was also noted as a crucial point at which patients then began seeking 
information. Most studies described patients’ as feeling the emotional impact of their 
cancer diagnosis and their feelings of vulnerability superseding the need for the use of 
information support aids. In contrast to this, Dickerson et al. (2006) reported that many 
‘internet savvy’ patients used the internet to gain an understanding of disease and to 
research the possibilities for cancer treatment once a cancer diagnosis was suspected. 
 
Rozmovits and Ziebland (2004) note that immediately after diagnosis many were too 
shocked to take in information but, within a few days, their need for information evolved 
into a sense of urgency for treatment. One participant in their study describes their 
experience: 
 
“I went right head–on into it, to get it done. To get it taken care of, I mean, I was going to 
go for a second opinion, but it was there. You know as someone said, “why don’t you go 
for a second opinion”, but when I went back and she showed us the pathology reports, the 
cancer is there” (Unknown, Rozmovits and Ziebland 2004). 
 
All studies reported that participants were not completely satisfied with the support 
that professionals provided for them prior to cancer treatment (Balmer, 2005; Lacey, 2002; 
Rozmovits and Ziebland 2004; Dickerson et al. 2006, 2011; Thygesen et al. 2011, 
2012). Experiencing a sense of uncertainty, patients subsequently responded by seeking 
information from a variety of sources including family members, friends, physicians, 
support groups and various forms of media. The internet was most commonly used for 
various purposes including understanding the disease, treatment possibilities, and decision-
making. 
 
“You get a lot of information verbally and you remember most of it, which I did, but when 
I went home I realised I didn’t fully understand the implications...it was just a lot of 
information and a lot of words and I didn’t really know what it meant. For example, they 
say “we found abnormal cells but we don’t know if its invasive, come back on Tuesday 
and you go away...and you think I don’t know what that means... you get a lot of verbal 
information but it’s very hard to take in at the time, especially if you are on your own” 
(Breast cancer patient. Rozmovtis and Ziebland, 2004). 
 
This quote indicates that whilst the patient expects consultants to provide adequate 
information this was not always achieved. Lack of time, preference for 
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particular forms of treatment and poor communication skills were common problems 
(Thygesen et al. 2011). Arguably, these factors could have collectively contributed to a 
patient’s distress and sense of vulnerability, to mistrust in healthcare professionals and so 
increased the difficulty of coping with a serious illness. 
 
Lacey’s (2002) study emphasised the inconsistencies in patient experiences of health 
professions in terms of their communication skills and expert knowledge. While some 
participants felt safe and secure with their consultant, others felt nervous: 
 
“I just wished that they would give me an opinion ...but they didn’t and this made me a 
little nervous” (Unknown, Lacey 2002). 
 
Balmer’s (2005) study reported that the majority of participants expressed faith in the 
information they had received from health professionals, though a hint of pessimism was 
also present in their experiences. Some patients conveyed a sense of obligation to believe 
and rely on health professionals as though information from other sources might lead to 
confusion and doubt. 
 
 “I just decided that the people here are the experts. I’ve got to trust them because if I 
don’t what else can I do? There’s no point in taking yourself down other avenues if you’ve 
elected to do what the consultants told you. You don’t want to read too much in case you 
start going 
...mmmmm” (Balmer, 2005). 
 
 
Participants described unhelpful experiences concerning information given by health 
care professionals and this caused them to rely more heavily on other sources of media-
produced information. 
 
This was evident from the quotation below: 
 
 
“It’s complex, the outcomes of the treatment are the same, it is what you go through to 
get there.” (Unknown, Dickerson et al. 2011) 
 
Patients generally expected health care professionals to give information in a way that 
they could understand. However, in reality the results from studies showed that 
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physicians were not always viewed as the ones with all the expertise and knowledge. 
This often resulted in the patient seeking information from elsewhere as well as from the 
primary specialist involved in their care. 
 
Trust 
 
In all studies the patients’ reported that they sought information about their cancer 
throughout the course of the disease, from the point of diagnosis to treatment and 
beyond (Lacey, 2002; Rozmovits and Ziebland, 2004; Dickerson et al. 2006; 2011, 
Thygesen et al. 2011; 2012). They explained that, once they were over the initial shock 
of the diagnosis, they tried to acquire as much information as possible from a range of 
different sources. These sources included medical professionals (most often), followed 
by the internet; nurse navigators; as well as print (e.g. pamphlets, leaflets, books) and 
television media to aid their decision making as well as coping/symptom management 
over the disease trajectory. It was apparent that the patients trusted and needed physicians 
to make the decisions for them (Lacey, 2002; Dickerson et al. 2006, 2011). 
 
 “Well, the physician gave me all the possibilities of what it possibly could be and if this 
is cancer, how he would recommend that we would take care of it. He just made me feel 
really comfortable” (Unknown, Dickerson et al. 2006). 
 
Thygesen et al. (2012) also identified that the use of a nurse navigator decision aid 
depended on the nature of the patient’s hospital experiences. For example, negative 
hospital experiences w e r e  d i s c l o s e d  to the nurse navigator. Prior to meeting the 
nurse navigator, they had built up “guarded trust” in health care professionals and the 
hospital system as a whole. 
 
“Doctors come and go as they see fit...they come and say their bit and they leave 
again...as far as turn their back on you at the same time, I mean ...really!” (Unknown, 
Thygesen et al. 2012). 
 
Some media sources were deemed better and more credible than others. The Internet was 
consistently seen as the most trustworthy source and the information it contained was always 
considered valid and valuable. 
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“You can’t always believe what’s in the newspapers: the media hierarchy. (Unknown, 
Balmer, 2005) 
 
Individuals who had feelings of mistrust with their physicians sought information from other 
sources or they switched from consultants, who gave them the “impression of them being 
pushed out of the door”. In terms of the internet, patients related that although they used the 
internet they tended not to take the information as absolute truth but with a “grain of truth” 
(Dickerson et al. 2006; 2011) 
 
Purpose 
 
Most of the studies reported on the nature and purpose of information patients sought 
from sources other than their primary medical contact (Lacey, 2002, Rozmovits and 
Ziebland, 2004, Dickerson et al. 2006; 2011, Thygesen et al. 2011; 2012). Approximately 
half of the studies cited internet use as the most widely used form of media accessed by 
patients, beyond initial advice from medical professionals (Ziebland and Rozovits, 2004; 
Balmer, 2005; Dickerson et al. 2006; 2011). 
 
Balmer’s (2005) study defined information sought by patients into two main categories 
1) “technical stuff” and 2) “life stuff”. In broad terms, two other studies also defined 
participants as seeking information in this way (Rozmovits and Ziebland, 2004; 
Dickerson et al. 2006; 2011). Researching medical information and difficulties in 
understanding medical terms also triggered internet searches as reported by one patient in 
Balmer’s (2005) study: 
 
“When they first told me I had this disease, they said there was no cure. We went on 
the computer and we found out that wasn’t necessarily the case. Here was...something 
more that could be done...there was more hope for me. They were doing good things with 
bone marrow transplant...(my daughter) got ...updated information...that made it really a 
lot better for us, even though it was risky.” (Unknown, Dickerson et al. 2011). 
 
The same study also reported the cautious way in which patients processed information 
from the internet: 
 
“Sometimes I am afraid to get on the (internet)...if it’s going to happen to me. I don’t know 
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if I really want to know that, although I know that these are things that are going to happen 
and I suppose I should be prepared.” (Unknown, Dickerson et al. 2011). 
 
Patients typically used the internet for learning about “life stuff” as opposed to 
“technical stuff”. “Life stuff” included coping with day-to-day reality of living with 
cancer, practical and emotional support (Dickerson et al. 2006; Rozmovits and Ziebland  
2004).  Patients related well to “other people’s stories” about their cancer experience and 
found it very useful (Balmer 2005). 
 
Patients reported mainly positive experiences, as one participant describes: 
 
 
“Going to the internet and seeing other people having the same ideas and problems were 
a big help. Reassuring like nothing else did” (Unknown, Dickerson et al. 2011) 
 
Therefore, the content of information provided by medical professionals and the level 
of familial support influenced the extent to which patients accessed information 
beyond the medical health setting. These positive or negative experiences influenced a 
patient’s beliefs about treatment success which in turn had an impact on their feelings of 
trust and sense of safety and attachment with health professionals. Qualities such as 
good communication, information giving and support were all positively viewed and the 
Nurse Navigator (NN) was often used to explain the medical information that patients 
were given. Staff responses towards patients, including lack of information pre and/or 
immediately post diagnosis, contribute to maintaining hope and a sense of vulnerability 
prior to treatment. 
 
Value 
 
 
Participants tended to use this information to both facilitate encounters with their providers 
as well as monitor their own health status for the cancer reappearing. For some 
patients, the more knowledge they held about their condition, the more proactive they 
were when dealing with the healthcare professional involved in their care in relation to 
their treatment. ‘The men used this increase in knowledge as a currency to enhance their 
own sense of control and power in the patient provider interactions’ (Dickerson et al. 2011). 
 
‘While they asked for clarification and came prepared with a list of questions they often 
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used their physicians as the end point for verification of the decision’  (Dickerson et al. 
2011). 
 
If the patient perceived web information as credible and usable, they then shared this with 
trust in the physician which ultimately influenced final decision making. The majority of 
cancer patients collated internet information with ‘a grain of salt’ but appreciated 
being able to access potentially distressing information, without the emotional demand 
(Rozmovits and Ziebland, 2004). 
 
Individuals who had received help from the NN experienced a mutual connection and 
they quickly built up confidence in the NN (Thygesen et al. 2006; 2012). However, those 
that did not seek help from the NN had close relations with a healthcare worker who 
helped them in the same areas as the NN (Thygesen, 2012). 
 
 “I have not used the NN because I have my children (one of whom is a healthcare 
professional and) she has followed me through this (at discharge)” (Unknown, Thygesen 
et al. 2006; 2012). 
 
In Rozmovits’s and Ziebland (2004) study, patients positively described their use of 
the DipEx website from which they could select and view the life and illness profiles of 
cancer patients and felt that this greatly reduced feelings of fear and isolation during their 
illness. In addition to this, the majority of participants in this study expressed that this 
would have encouraged them to become more active decision makers about treatment. 
However, the lead researcher and interviewer of this particular study was also involved in 
the development of the website which may have resulted in researcher bias and the 
favourable reporting of results. 
 
The internet was accessed to seek information about specific types of cancer and validate 
treatment recommendations. Sometimes this enhanced confidence but other times 
created fear. ‘Internet savvy’ patients explained how they searched for accredited sites, 
verifying the information with other websites and had the most confidence in sites which 
were affiliated with health service organisations (Dickerson et al. 2011). 
 
“There was one lady with non-Hodgkin’s lymphoma and she was writing a sort of 
celebration of her life; how she got through it. She lost her hair but its growing 
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back and she was talking about going on holiday. Yes that was interesting. In fact, quite 
inspiring” (Unknown, Balmer 2005). 
 
On completion of treatment participants differed in the amount of information they 
required. A minority felt it was more helpful to move forward and ‘leave it all behind’. 
However, most felt they would always have an interest and continue to seek information 
(Rozmovits and Ziebland, 2004; Thygesen et al. 2011; Dickerson et al. 2006; 2011) 
about coping with the day-to-day reality of living with cancer or the possibility of 
recurrence, including practical and emotional support. 
 
 
 
 
DISCUSSION 
 
 
This systematic review has used meta-ethnography to obtain new insight and meaning 
into how patients use decision aids (DAs) within the cancer setting. The aim has been to 
enable a better understanding of earlier quantitative reviews that identified DAs as 
effective in reducing anxiety, decisional conflict and improving knowledge about their 
illness and treatment. The methods of synthesis used encompassed all of the types of 
information aids cited in previous quantitative investigations of patient DA use: pamphlets, 
internet websites, nurse navigators, and CDs. Four major concepts have been identified: 
(i) Knowledge (ii) Trust (iii) Purpose (iv) Value. The themes were closely linked 
objectively and subjectively, as reported by the patients themselves. 
 
Main Findings 
 
Similar to the present discussion of trust, the literature reflects that patients have 
personal trust (e.g. specific health care professional), and more generally, social trust in 
healthcare systems and practices (Hunter and Maunder, 2001). When patients feel 
vulnerable, they are likely to seek closeness and attachment to a person they consider 
reliable and safe to help (Bowlby, 2008). The health professional may become a trusted 
person to the patient given their need for closeness and reassurance (Salmon and Young, 
2009). In line with quantitative reviews (O’Brien et al. 2009) DAs, appear to have enhanced 
patients’ sense of empowerment, problem-solving and peer support, as well as facilitating 
decision-making about treatment and coping with the disease. The present review 
distinguishes that, regardless of type, information aids perceived as trustworthy and 
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tailored to patient need are most beneficial to patients. More specifically, this review 
demonstrates that t h e  cancer patient can benefit from other cancer patients’ stories based 
on their coping with the illness. Information is gained predominantly from the clinician 
involved in their care and supplemented by the internet being used to facilitate 
consultations, research signs of cancer recurring and validate treatment decisions. This 
has in turn influenced patients’ emotional reactions, resulting in a reduction of fear and 
isolation and enhanced coping with the disease. 
 
 
Figure 5: Emergent themes 
 
 
 
 
 
 
 
 
Across the cancer journey 
 
 
 
Methodological challenges 
 
The requirement of identifying and evaluating methodological difficulties to challenge 
the findings of a study remains a significant issue in the assessment of qualitative research 
(Guba and Lincoln, 1994). As in quantitative research, the robustness of findings may 
depend on the specific design or method chosen (Noyes et al. 2011). 
 
Intervention to 
facilitate cancer 
patients 
decision making 
about treatment 
Why are 
patients seeking 
to advance their 
medical 
knowledge 
alongside their 
routine care? 
What sources of 
information do 
patients 
trust/use? 
What type of 
information is 
sought, and 
what purpose 
does this serve? 
How does this 
information 
meet the needs 
of cancer 
patients, what is 
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The methodological evaluation suggested a number of strengths and limitations within 
the literature. The majority of the studies demonstrated strengths in methodology, 
particularly in scope and purpose, design, data collection methods and sampling strategy 
which were reported by all researchers. Not all studies were explicit about analysis and 
not all described the process of data saturation. Few studies mentioned that findings were 
validated  and whether themes were crosschecked. It became apparent that the themes 
identified by the authors were not definitive or easily separable. Whilst authors used 
different labels to identify similar themes, the content did not necessarily differ. Only one 
study explicitly reported auditability of the research process and findings. This was 
surprising since it is the actual audit trail, provided by researchers, that allows for an in-
depth evaluation of a study (Hannes, 2011). All studies used interview data to support 
their interpretations.  
 
The majority of studies described the relevance of their findings in the context of 
literature and reported directions for future research and clinical implications. However, 
some failed to report weaknesses or limitations. Researcher reflexivity was also another 
aspect that was poorly demonstrated, if at all, by the studies included for review. Only one 
study reported the possible influence of the interviewer during the data collection process. 
In relation to ethical standards, some failed to mention any details regarding ethical 
approval, explanation of research to participants, procedure for informed consent or 
ensuring confidentiality. 
 
Overall, there is significant debate in the literature regarding whether or not concepts such 
as validity and reliability are applicable to qualitative research and if so, how they 
should be evaluated. Some researchers have stated that qualitative research should 
establish validity, reliability and objectivity. Other authors argue for a modification of 
these concepts to provide a better fit in the qualitative research design (Guba and Lincoln, 
1994). 
 
Strengths and limitations of this review 
 
Strengths 
 
The author is not aware of any other syntheses of qualitative literature investigating 
patients’ perceptions of DA use in the cancer setting. Qualitative meta-synthesis is still 
an emergent field with little consensus on a single way of doing it. Following the 
principle set out by Miles and Huberman (1994) of establishing a clear research question, 
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this study has sought to present findings encompassing transparency and explicitness. To 
ensure robustness, the articles were independently read and coded. The methods of the 
study were also explicitly described and presented in written and diagrammatic form. 
Reaching clarity about how each theme translated into another and how higher order 
interpretations were formed was also attempted. The researcher also attempted to ensure 
that themes were grounded in the papers' findings by systematically returning to the text of 
the original articles throughout the analysis process.  
 
Limitations 
 
There are a number of limitations to the current review which should be addressed. 
Only published studies, from this small and emerging field, were included in the current 
review and research papers were limited by the search strategy used. Therefore, there 
may be a publication bias, meaning other relevant studies may have been excluded. 
Within the literature, a bias was evident with regard to DA experiences of patients 
diagnosed with breast or prostate cancer as opposed to other forms of cancer. This may be 
because use of DAs has been more frequently investigated in prostate and breast cancer 
patients than in any other form of cancer. However, this may also reflect the fact that 
breast and prostate cancer are among the most frequently diagnosed cancers in the 
world (World Health Organisation, 2014). The views of those who did not wish to 
participate were also not recorded and this possibly resulted in a group of patients who 
are underrepresented. Arguably, the results of the systematic review may only represent 
the information needs of groups that are willing to participate and they are 
predominantly breast and prostate cancer patients. The methodology of each study was 
assessed and many of those considered for review demonstrated methodological 
weaknesses. The findings of these studies were not excluded based on this but still 
synthesised in the context of the methods used by each study. Finally, the validity of the 
meta-synthesis could have been improved by returning the interpretations to the original 
authors and researchers involved in the research studies. 
 
Reflexivity 
 
 
Although the current review captured the main themes from the studies, the review 
was predominantly subjective. Therefore, the values and beliefs of the reviewer may have 
influenced her interpretation of themes within the synthesis (Pope et al. 2007). However, 
the reviewer also believes the findings were strengthened by her professional 
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background. The field supervisor is a consultant clinical psychologist at a national cancer 
centre. The academic supervisor has a specialist research interest in communication among 
health care professionals and their patients, within the health care setting. Discussions 
with supervisors encouraged the researcher to think conceptually allowing patterns and 
themes to emerge and thus permitting interpretations of data. A possible strength of the 
review is that it included samples of participants from various outpatient settings and 
monitored the changing information needs of participants over the development of the 
disease/treatment. 
 
Clinical implications and directions for future research 
 
 
This synthesis emphasises the key role that health care professionals can play through 
providing cancer patients with information or decision aids that embellish trust and 
are sensitive to their individual needs. DAs provided in this way can influence an 
individual’s ability to facilitate encounters with healthcare providers in various ways. For 
example, the cancer patient may be able to better monitor their own health status, 
validate or make decisions about their treatment as well as cope with and manage the 
disease. It is hoped that this review will provide researchers and clinicians with an 
understanding and context, informed uniquely by the patients’ subjective experiences and 
reflections, about why and how they use information aids in clinical practice. 
 
For health care professionals, this review suggests that patients’ wish to have the option to 
be actively involved in treatment and care decisions. It would be of importance, therefore, 
for services firstly to seek out the individual information preferences of their patients as 
endorsed by policy. For example, clinicians can explore with the patient the level of 
support within their family system and other sources of information used to supplement 
the information given to them. This may subsequently lead to onward referral to general 
sources of information, e.g. NHS based websites, or more tailored approaches, e.g. nurse 
specialist or navigator, to supplement the information given to them at consultations. 
This review has shown that cancer patients relate particularly well to the personal stories 
of survivors’, regardless of the type of DA. This is an important finding that can be 
incorporated into the design of any intervention and content of interaction aimed to 
facilitate the doctor patient encounter. 
 
The themes from this review have elucidated that trust in individual clinicians and sources 
of information remains paramount when supporting cancer patients with decision aids. This 
can positively influence patients’ sense of empowerment, reduce anxiety levels and 
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enhance decision making about treatment. The overlapping of themes reflects the 
importance of checking on the evolving information needs of cancer patients throughout 
the journey of their cancer, involving family members and tailoring information to meet 
the needs of individual patients. For researchers, the review identifies areas for future 
research. Firstly, the review emphasises the need for further qualitative research evaluating 
DA use among cancer patients in the NHS setting, where all but two studies were carried 
out in the United Kingdom (e.g. Balmer, 2005; Rozmovits and Ziebland, 2011).  
 
A focus on developing information aids that are tailored to individual consultation 
content and evaluation of the impact of this among patients in different cancer care 
settings such as palliative care is also required (O’Brien et al. 2009). Surprisingly, given 
the growing availability of charity-based support for cancer patients, the narratives of 
cancer patients did not reflect use of support from cancer charities in relation to any aspect 
of living with cancer. Future research could consider the impact of other forms of support 
including charities as well as the media on patients’ experiences in relation to illness 
management. Exploring the impact of particular components of DAs, in relation to one 
another, such as the usefulness of patient stories in coping with cancer in comparison to 
advice on practical support on living with cancer as provided by healthcare 
organisations, might also be considered for future research. 
 
Conclusions 
 
This meta-synthesis implies that the search for information about cancer out with the 
medical setting, whether recommended by clinicians or not, can be precipitated by 
negative interactions with healthcare professionals or by lack of support from within 
their existing network of friends and family. It also recognises that from the patient’s 
perspective, optimal healthcare can only succeed if there is trust in the healthcare 
provider and the information given. In countries such as Denmark, the United States of 
America and Sweden private health care insurance is required which may influence the 
level of care a patient with cancer experiences. Therefore, it cannot be assumed that 
information interventions alone will be deemed credible, valid, consistent, culturally 
sensitive and available from the onset. If health care professionals in the cancer setting can 
identify an individual patients information needs during clinic appointments, then they can 
also signpost them to receive the relevant support such as internet websites, nurse 
navigators or specialists that can provide information tailored, as much as possible, to 
individual patient need. 
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By understanding the subjective experiences of cancer patients who use DAs, clinicians 
can identify why and how patients make use of DAs to meet their unique informational 
needs. They can thereby provide tailored DAs that have been shown to facilitate 
encounters with doctors, monitor their health status for recurrence, reduce fear and 
isolation, validate treatment decisions and enhance coping with the disease. Whilst the 
purpose of this systematic   review   was   to   supplement   existing   quantitative   reviews   
with   patients’ perspectives, (e.g. O’Brien et al., 2009) and gather research knowledge 
concerning the topic regardless of the strength of the evidence, the methodological 
shortcomings of studies included for review perhaps limited the strength of the findings. In 
terms of service redesign and informing policy, researchers might be able to improve the 
methodological strength of findings by employing a model to assess the trustworthiness 
of findings (Guba and Lincoln, 1994). This would involve measures such as an audit trail, 
peer examination, reflexivity and triangulation. Finally, the researcher acknowledges the 
considerable cost implications attached to developing DAs tailored to a cancer patient’s 
needs, in terms of coordinating, developing and distributing DAs affiliated to the health 
organisations that patients attend. However, it is hoped that this review can provide 
credible and original evidence required to justify the allocation of resources to the 
development of DAs or alterations to the content of service delivery required to meet the 
evolving needs of cancer patients. 
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ABSTRACT 
 
 
Background: In comparison to other medical appointments, consultations regarding 
haematopoietic stem cell transplant (HSCT) tend to be emotional and longer due to the 
high volume and content of information exchanged between the patient and consultant. 
HSCT offers the potential to cure the cancer but also carries a multitude of life-
threatening side effects. Existing research has shown that patients immediately forget the 
majority of information they receive in medical consultations thus resulting in 
misunderstandings about treatment, adjustments and about coping post transplant. 
Despite this, no previous research has evaluated cancer patients’ level of recall and 
understanding considering the volume of information they receive from doctors during 
consultation for HSCT. 
Aim: To create, within a haemato-oncology setting, a coding framework capable of 
evaluating the interaction between the patient and doctor in the HSCT consultation. 
Methods: The medical consultations of five HSCT patients who were eligible for 
HSCT were recorded and these patients subsequently completed semi-structured 
interviews. Transcripts were analysed using directed content analysis. A recall and 
understanding information template (RUIT) with an associated coding framework was 
developed and piloted. 
Results: The procedures undertaken in developing the RUIT demonstrate strong inter-
rater reliability and content validity. Further testing, through piloting the instrument, 
indicated that the RUIT coding system has strong inter-rater agreement. However, 
disparity in the classification of some categories was also revealed. Cancer patient’s 
viewed the consultation as informative but also felt that both the content and volume of 
information they received were difficult to process. 
Conclusions: This study is the first qualitative investigation of cancer patients’ recall 
and understanding of content from a HSCT consultation through the unique 
development of a coding framework. Future use of the RUIT in clinical practice and 
recommendations for further research are discussed in relation to the relevant literature. 
 
 
Key words: Haematopoietic, recall, understanding, consultation, content analysis 
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Introduction 
 
 
Cancer patients’ information needs 
 
 
The World Health Organisation (2014) reports that cancer is becoming a leading cause 
of death globally. Prevalence is increasing in both solid tumours and blood cancers due 
to a combination of improvements in prognosis and screening techniques, as well as to an 
increase in incidence (Cancer Care in Scotland, 2014). Solid tumours consist of an 
abnormal mass of cells that typically stem from different tissue types such as the liver, 
colon, breast, or lung. In contrast, haematological malignancies are cancer types 
affecting the blood, bone marrow and lymph nodes. Given the rise in detection and 
treatment of cancer, researchers are seeking to increase their understanding of the nature 
and extent of the doctor-patient relationship in the cancer setting (Carlson et al. 2005). 
Consequently, more recently, there has been an increased focus on investigating cancer 
patients’ information needs. 
 
The communication process is the vehicle through which a trusting relationship with 
the patient can be established by providing cancer related information sensitively and 
responding to the psychosocial needs of the patient (Hack et al. 2005, Brundage 2010; 
Fagerlind et al. 2012). The essential criteria for successful interactions between health 
care providers and their patients are that the amount of information given is “adequate, and 
that it is understood, believed, remembered and hopefully acted upon” (Fallowfield and 
Jenkins, 1999 pp. 34). Communication regarding disease status should embrace 
discussion about tests, available treatments and information about both physical and 
psychological symptoms. There is often a significant mismatch between doctor and patient 
understanding of prognosis, suggesting poor communication of this aspect of disease 
status which can lead to over estimation of life expectancy (Butow, 2005; Rodriguez et 
al. 2010). 
 
It has also been suggested that patients who misunderstand aspects of their consultation 
are less satisfied overall with the service they receive. This, in turn, can result in poor 
decision making about cancer treatment, misinterpretation of consent procedures, 
increased anxiety, poor adherence to treatment adjustment and difficulties coping with 
treatment side effects (Hagerty et al. 2005a). Individuals with cancer, therefore do not 
easily understand cancer and its treatment and efforts ought to be made to detect and 
clarify misunderstandings that subsequently mislead the patient. 
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Debate has taken place regarding the most appropriate research methods to assess 
communication within cancer consultations. Despite this, the need of cancer patients to 
receive satisfactory communication is poorly understood. For example, studies that 
employ quantitative methods use questionnaires or surveys developed by researchers 
that are not based on cancer patients’ experiences with clinicians (Carlson et al. 2005). 
Information about prognosis and the psychosocial aspects of quality of life have been 
omitted during informed consent trials and evaluations of consultations with patients who 
have been diagnosed with advanced cancer (Rodriguez et al. 2010; Jenkins et al. 2011). 
There is also a lack of clear agreement on guidelines to clinicians on how to provide 
information about cure and survival to cancer patients (Hagerty et al. 2005b). 
Collectively, these factors may contribute to a patient misunderstanding information from 
a cancer consultation. In particular, little is known about communication with patients 
suffering from haematological malignancies, despite significant differences between the 
outlook and treatment of haematological malignancies and other tumors (Rood et al. 
2014). 
 
Current communication research in the cancer setting 
 
Carlson et al. (2005) comprehensively reviewed research methods and outcomes most 
commonly used to investigate the doctor patient interaction in the cancer setting. They 
found that many variables have been identified and their effects investigated. They are: 
the interpersonal skills of the doctor (Hack et al. 2005; Jenkins et. al 2011), patient 
satisfaction, compliance (adherence to treatment), knowledge, recall, understanding, 
coping, status, psychological state (e.g. anxious or depressed) (Ong et al. 2000) overall 
quality of life (Fagerlind et al. 2008) shared decision making (Thorne et al. 2010), and 
prognosis (Hagerty et al. 2005b). The authors used the conceptual framework of Feldman-
Stewart et al. (2005) to characterise communication exchange within the cancer setting 
through five inter-related dimensions which they propose can enhance or hinder successful 
communication (Figure 1). The authors concluded by recommending that future methods 
used to evaluate doctor patient communication in the cancer setting ought to include data 
collected through patient interviews, as well as objective measures such as video and audio 
recording. 
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Figure 1. Feldman-Stewart et al.’s (2005 ) conc eptual framework for patient -
professional communication 
 
 
 The first dimension focuses on the interaction between each person’s 
communication goals and their perceived outcomes. Goals are defined, as an 
expression of each person’s needs, with the aim that they should be met. 
 The second dimension focuses on five key characteristics intrinsic to the patient 
and doctor, including; skills, needs, values, beliefs, and emotions that enable the 
professional and the patient to work together towards their goals. 
 Other components of the framework encompass the environment and external 
factors used to represent communication that occurs in the cancer setting. 
 The communication process, the final element of the framework (and focus of 
this thesis) involves conveying and receiving messages. These include verbal 
messages (e.g. discussion of the disease, prognosis, and quality of life) as well as 
non-verbal behaviours (e.g. body language and facial expressions) that may 
influence what may or may not be understood and recalled by the patient. 
 
Communication research in the haemato-oncology setting 
 
The most substantial review of the information preferences of individuals’ with a 
haematological malignancy is provided by Rood et al. (2014). The authors reviewed 
14 studies with a total of 1938 participants with various diagnoses of a haematological 
malignancy. They included both quantitative and qualitative studies that investigated 
the informational needs of this population, the sources of information used and satisfaction 
with the information received by their doctors (Yogaparan et al. 2009; Mohamedali 
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et al. 2010; Parry et al. 2011). The review suggested that almost all patients’ wanted 
basic information about their diagnosis, specifically treatment related information rather 
than psychosocial information. The need for detailed information was varied, with 
individuals preferring basic information on treatment. Where HSCT was an option, 
general details were valued over indepth information. Rood et al. (2014) cited a number 
of papers which showed consistency between doctors and patients in relation to the 
importance and need for medical information. However, this was not demonstrated in 
relation to the need for psychosocial information. 
 
Research has shown that the amount of information given during cancer care 
consultations can be difficult to process and without clear content and structure (Carlsson 
et al. 2013) can potentially give rise to poor recall and understanding of information 
(Fagerlind et al. 2008; Grulke and Bailer 2010, Rodriguez et al. 2010). Patients’ who 
consider they have not received enough information or misunderstand the information 
they have received can be left with increased feelings of uncertainty, anxiety and 
confusion. This will result in their needs not being fully met (Hacking et al. 2013; 
Fagerlind et al. 2012). In line with the findings, from these earlier studies the Rood et al. 
(2014) concluded that although there is a considerable knowledge on what constitutes 
good communication between doctors and patients’ with haematological malignancies, 
studies focusing on what comprises doctor-patient communication in the HSCT 
consultation is limited, indicating that further research is needed. 
 
Friis et al. (2003) described the information needs and information seeking behaviour 
from the perspective of patients’ with acute myeloid leukemia. The authors used 
qualitative ethnography, interviewing each of the 21 participants at two separate time 
points; firstly at the time of diagnosis and again 2 to 5 months post diagnosis. Most 
patients demonstrated poorer recall of information immediately after diagnosis. The only 
information they did recall related to the diagnosis and their emotional state. In contrast to 
the results of earlier studies, the participants under investigation did not seek detailed 
medical knowledge about their illness (e.g. prognosis) and treatment. Participants 
attached more importance to information about problems affecting their everyday life 
and how other persons had coped with their illness. 
 
Grulke and Bailer (2010) investigated the level of agreement between patients’ and 
doctors’ estimations of prognoses prior to HSCT, using quantitative methodology. Patients 
and doctors were invited to estimate the patients’ chances of cure on a Lickert scale 
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as well as indicate psychological state and coping on self report questionnaires. The 
agreement between doctor and patient prognosis estimates was found to be poor. Doctors’ 
ratings were positively correlated with actual survival but patients’ ratings were not. In 
terms of psychological state, the authors’ found that patients’ evaluation of their prognoses 
was highly correlated with their distress. They hypothesised that psychological processes 
such as denial or repression are most likely to impact on concordance. However, the 
authors’ failed to provide specific descriptions in relation to the categories and rating 
system used. Validity can be compromised if the content of a questionnaire is not based 
on previous qualitative research or if methodology is not easily replicable. 
 
Alexander et al. (2012) evaluated 236 initial sub-specialty consultations between 
haemato– oncologists. They observed that haemato–oncologists underuse many 
mechanisms that may enhance communication and the usefulness of the consultation. 
Typically, the consultation tends to cover a preference for an information and decision-
making role, and checking patients’ understanding of presented information. Haemato-
oncologists discuss quantitative estimates of mortality and cure resulting in highly 
emotionally driven content with patients they are meeting for the first time. Most 
commonly information about the purpose of the visit and patients’ knowledge about their 
disease were discussed. Other elements such as a patient’s preference for their role in 
decision-making, preferences for information, or understanding of presented information 
were also discussed. Treatment recommendations were provided in 97% of the 
consultations and unambiguous presentations of prognosis occurred in 81% of the 
consultations. They concluded that by evaluating the information patients receive from 
the consultation, doctors can tailor the amount and content of information they share with 
them. 
 
Whilst this is the only study that has set out to characterize the content of the HSCT 
consultation, it has also provided a useful basis for the present investigation of 
haematological cancer patients’ consultations with their doctors and an indication of 
the methods required to measure patient recall in this specialist consultation. On the other 
hand, the study lacks transparency of methods, by failing to make explicit the type of 
qualitative analysis used. 
 
Assessment of patient recall and understanding of information from cancer consultations 
 
 
Patient recall of cancer treatment consultations has previously been defined and 
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measured empirically (Fallowfield and Jenkins 1999; Carlson et al. 2005; Jenkins et al. 
2009). Although the research literature fails to provide a clear operational definition of 
patient understanding of cancer treatment, the concept has been measured (Jenkins et 
al. 2008). Assessment to improve the communication process will help guide 
development of interventions that may enhance reaction to treatment related difficulties. 
 
Jansen et al. (2008) investigated older cancer patients’ recall of information after 
patient education, preceding chemotherapy. Jansen and colleagues devised a recall 
questionnaire which consisted of multiple choice questions related to information 
about treatment and recommendations using a combination of multiple choice and 
open-ended questions. The recall questionnaire was a combination of a chemotherapy 
guide and coded pilot vidoes, which provided the basis for potential topics that could be 
discussed. Recall was subsequently compared to the actual communication in the video 
recordings of the consultation. 
 
Results from Jansen et al’s. (2008) study showed very low recall scores that the authors 
partly attributed to the scoring system used. The observation checklist used covered the 
specific items of the consultation very precisely and a one on one comparison was made 
between the items presented (using videotapes of the consultation) and recalled. At no 
point were items prioritised to be of greater importance from the doctor or patients 
perspective. Recall was measured solely using a recall questionnaire and recall was not 
probed. Should such a methodology be used to test recall, it will increase the observed 
recall rate, in comparison to what the authors found using the questionnaire alone. 
 
Jenkins et al. (2011) demonstrated that misconceptions could arise between patients 
and doctors during the informed consent processes for clinical drug trials in the cancer 
setting. Consultants completed questionnaires indicating areas they felt they had discussed 
and researchers performed semi-structured interviews with patients examining their 
recall and understanding. Independent researchers coded the consultations, identifying 
discussion of key information areas. Results showed that information was either missing or 
had been explained but was interpreted incorrectly by patients. They found that 
discussion of prognosis andpatient understanding about supportive care were frequently 
omitted, with patients and coders significantly more likely to agree that consultants had not 
discussed the topic. 
 
Developing methodology to measure communication in the cancer setting 
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In developing the methods for this study, it was useful to consider the work of past 
researchers, particularly Roter (1987), who was instrumental in developing scales for 
the measurement of communication in the health care setting. Roter (1987) devised a 
coding and classification system to enable researchers to study the content of doctor-patient 
encounters. 
 
Roter and Larson (2001) proposed that before researching doctor-patient communication, 
we must ask ourselves why particular communication variables merit measurement and 
where the variables fit in a broader conceptual and theoretical framework. Roter and 
Larson (2001) identified a weakness as ‘the relative absence of theoretical focus to 
guide investigators in making basic judgments regarding what to measure, when, and 
why. This deficit has contributed to the largely exploratory nature of work in this 
field with little conceptual framing of results’. (p.243) 
 
Instruments developed for systematically analyzing medical consultations are most 
commonly termed “Interactional Analysis Systems” (IAS) which involve coding, 
quantifying, and scoring audio-recorded patient physician dialogues. The most widely 
used IASs measure medical based information as well as associated psycho-social 
functioning such as the Roter Interaction Analysis System (RIAS), CN- LOGIT and the 
Medical Interaction Process System (MIPS). Use of these systems is limited by their 
complexity and training requirements (for full review see Ong 2000). 
 
A comprehensive review of all instruments developed for communication analysis is 
beyond the scope of the current paper. Therefore, summaries of the most commonly used 
evaluation frameworks within the cancer care setting are presented in tabular form in 
Appendix 2.1. 
 
The importance of qualitative methods to explore communication 
 
Many of the IASs have shown satisfactory reliability and validity, investigating the quality 
of the doctor-patient interaction and providing knowledge on patient related outcomes. 
Typically these have included shared decision making, satisfaction with information, 
consultation length, eye contact, speech clarity and use of the vernacular (Dunn, 
2005). 
Qualitative research has shown that use of such methods in studying communication may 
be based on assumptions that are not congruent with the needs and lived experiences 
of the patients themselves (Thorne et al. 2005). Another disadvantage of using such 
methods is that the context seems to be lost because of the separation of information 
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into coding units, often consisting of one sentence or less (Fagerlind et al. 2008). 
Increasingly, it has been acknowledged that qualitative methods can be more informative 
in assessing the communication between the patient and doctor, if tailored to the 
individual type of cancer consultation (Rodriguez et al. 2010; Fagerlind et al. 2012). 
 
Previously qualitative methods have typically been applied to the process component of 
the communication framework (Feldman-Stewart et al. 2005) These are: studying the 
relational aspects of the cancer consultation such as delivering ‘bad news’, conveying 
hope, prognosis and shared decision making. As identified by Fagerlind et al. (2012) 
qualitative approaches allow the results to emerge without being filtered through an 
existing structured analysis system. Rather than components of a consultation being 
placed into preexisting categories, the categories are established based on the data 
whilst coding. This avoids imposing a predefined coding framework upon patient 
experience, instead allowing the foundations for measuring communication to emerge in 
this specific group of patients’. 
 
Qualitative content analysis, specifically, has been used to identify patient centered and 
psychosocial categories to communication analysis systems to supplement their existing 
validity (Fagerlind et al. 2008). Similarly, by using qualitative content analysis it is 
possible to identify what topics are being discussed during HSCT consultations and to 
develop a valid and reliable method of evaluating the HSCT consultation while postulating 
factors that may influence interpretation of this communication. 
 
Rationale for the qualitative evaluation of communication exchange in HSCT consultations 
 
Until very recently e.g. Fagerlind et al. (2012) there has been a lack of qualitative 
studies focusing on the communication content in oncology. Fewer still have investigated 
the communication processes that occur specifically within Haematopoietic Stem Cell 
Transplant (HSCT) consultations (Merckaert et al. 2009; Grulke and Bailer, 2010; 
Alexander et al. 2012). Unlike other medical treatments, HSCT is often started early to 
prevent progression of the illness. However, the procedure also involves a high risk of 
death and numerous life-threatening side effects such as fatal infections and major organ 
complications. If individuals’ choose to undergo HSCT then they face a short-term 
risk of fatality in the hope of the possibility of potential cure. Consequently, 
consultations regarding HSCT tend to be longer and highly emotional due to their 
complexity and the amount of information which needs to be given to potential transplant 
recipients regarding treatment options, processes and long- term side-effects. Given 
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the level of detail, length and focused discussion of treatment options, it is likely in 
the HSCT consultation there is a higher exchange of information than in many other 
medical consultations (Alexander et al. 2012). 
 
A review of the literature reflects a divide in terms of meeting patients’ informational 
needs, with some researchers arguing that in-depth and detailed information is 
necessary for the patient who attends for HSCT consultation. Other researchers argue 
that basic information about HSCT and its effects is all that is required to meet 
individuals’ informational needs. The need for detailed information is varied and 
haematological cancer patients express preference for basic information on treatment 
where HSCT is an option. There is consensus that doctors can tailor the amount and 
content of information if they are aware of the content that patients most likely remember 
and understand. 
 
This thesis aims to create a tool capable of identifying and comparing patient recall 
and understanding with the information they receive from their doctor during 
consultation for HSCT. The tool will be developed using qualitative content analysis 
and a coding system grounded in the theoretical framework by Feldman-Stewart et al. 
(2005) and methodology of relevant research on the topic (e.g. Alexander et al. 2012). In 
doing so, the complexities involved in assessing patient-doctor communication will also be 
elucidated. It is important that different assessment frameworks for different types of 
cancer consultations exist so that their distinctive characteristics can be taken into account. 
Currently there are no measures for assessing the area of HSCT consultations within the 
National Health Service (NHS) in Scotland. It is for this reason that it is the central focus of 
this thesis. 
 
The development of an instrument to capture the experience and nature of doctor-
patient communication is essential in gaining knowledge and understanding regarding the 
content of cancer consultations. Such an instrument would facilitate the delivery of 
patient centred communication in response to health service standards, particularly for 
medical procedures involving a high risk of death and a multitude of side effects such as 
HSCT (Merkaert et al. 2009). No previous studies have set out to understand, describe 
and measure patient recall and understanding in the context of HSCT consultations in 
Scotland. 
 
Research aim (s) 
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The aim of this study is to develop a tool capable of measuring recall and understanding 
of information given to a patient during consultation for HSCT, thereby contributing to 
the evidence base of communication measures used in oncology, and facilitating doctor-
patient communication resulting in improved care for patients about to undergo HSCT. 
 
Research tasks 
 
The objectives of this research were to: 
 
 
1) Develop a coding framework capable of evaluating the interaction between the 
patient and doctor in the HSCT consultation within the haemato-oncology setting, 
with the purpose of providing knowledge, new insights, a representation of facts 
and a practical guide to action; 
 
2) Determine the reliability, internal consistency and content validity of the of the 
coding framework, hereafter referred to as the Recall and Understanding Interview 
Template (RUIT), as it is at its current stage of development. 
 
Research design 
 
In addressing the reliability and validity of the RUIT, the researcher went through the 
processes depicted in Figure 4. Face, content and construct validity were addressed through; 
a literature review, an existing “work up sheet” currently in use by consultants and 
expert opinions from Consultants at the Beatson Oncology Centre. Inter-rater agreement 
was obtained regarding the categories defined and codes applied. 
 
Methods 
 
 
This qualitative study employed directed content analysis to code and analyse the recall 
and understanding of communication from the patient-doctor consultation about HSCT 
(Carlson et al. 2005), and uses pre-determined categories from the recall and 
understanding interview template (RUIT) (Appendix 2.2). 
 
A challenge to content analysis is the fact that it is very flexible as a result of which there 
are differences in agreement among researchers over what definitively constitutes content 
analysis and in particular the difference between qualitative and quantitative content 
analysis (Schreier, 2012). Therefore, it is the researcher who must judge which research 
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methods are most appropriate for their particular problem (Carlson et al. 2005) which 
makes the analysis process more challenging and interesting. While the importance of 
establishing the methodological rigour of research cannot be overstated, this takes on 
particular importance when the aim is to improve our understanding of a complex topic, 
using qualitative methods, which has received little prior attention in the literature such 
as the evaluation of patient’s recall and understanding from a HSCT consultation. 
 
There is a challenge, therefore, to identify ways that are appropriate to the research 
methods used to ensure transparency. The study used content analysis and it was decided 
therefore, to use the criteria identified by Guba and Lincoln (1994), to guide approaches 
to maintaining rigour. In an attempt to address the lack of appropriate criteria on which to 
judge qualitative research, Guba and Lincoln (1994) devised a set of four assessment 
criteria that could be used in qualitative and quantitative research studies: truth-value, 
applicability, consistency and neutrality. These can be defined and operationalised 
both in qualitative and quantitative research: 
 
Figure 2. Qualitative criteria for rigour and quantitative equivalent terms 
 
 
Concept Qualitative Quantitative How this is operationalized Techniques 
Truth-value Credibility Internal validity Purposeful sampling, constant 
comparison, member 
checking, triangulation, audit 
trail 
Field/personal notes, 
tape recorder, 
thematic log, auditing 
transcript 
Applicability Applicability External validity Purposeful   sampling,   ‘thick 
description’ 
Data display, 
simultaneous 
literature review 
Consistency Auditability Reliability Atypical  case,  triangulation, 
peer review, audit trail 
Field notes, tape 
recorder. Thematic 
log, auditing 
transcript 
Neutrality Confirmability Objectivity Audit trail Field journal 
Source: redrawn from Guba and Lincoln (1994) 
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In addressing the reliability, validity and objectivity of the RUIT, the researcher adhered 
to the guidelines proposed by Guba and Lincoln (1994) as far as possible. This process is 
shown in Figure 2. reliability and validity were addressed through literature review, expert 
opinions and inter-rater agreement on the coding scheme and topics contained within the 
RUIT. The methods of the study involved 3 distinct phases; each phase of the methods 
represents aspects of the study. This cumulative process facilitated careful construction 
and refinement of the RUIT. An outline of this 3-phase process is presented; 
 
1. development and validation of the RUIT 
2. pilot study, preliminary findings and RUIT refinement 
3. further development and validation of RUIT 
 
 
Phase 1: Development and validation of RUIT 
 
Item generation for RUIT 
 
Topics for the interview and RUIT coding schedule (Appendix 2.2) were developed based 
on the following; 
 
a) a   review   of   the   literature   about   measuring   communication   between   
health professionals and their patients in health care, more specifically the cancer 
setting, 
 
b) liaisons with the consultant psychologist and oncologists from the Beatson. The 
consultant clinical psychologist based at the Beatson Oncology Centre has 
experience of working with patients who are eligible for or have undergone HSCT. 
Therefore, the RUIT was refined in discussion with him. 
 
c) prior observation of HSCT consultations. 
 
Sorting the data 
 
The researcher began to sift through the data, identifying tentative hunches and themes. 
This involved scrutinising the data line by line. Clusters of coded data that fitted together 
began to emerge and the information collected was read through again. Headings were 
written down in the margins to describe all aspects of the content (Hsieh and Shannon 
2005). Similar topics were grouped under the same over arching heading as shown in 
Appendix 2.1 and 2.2. The aim of grouping data was to reduce the number of categories 
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by collapsing those that are similar or dissimilar into broader higher order categories. 
Examining the information in this way, the researcher was able to come to a decision, 
through her own interpretation, as to which segments of text/data to put into the same 
category. 
 
Overall nine main recurrent topics or variables were identified as being of relevance, 
including: clarification of information pertaining to patient’s current/past health and 
well- being, explanation of the treatment process, aims of treatment, side effects, Graft 
vs. Host Disease (GvHD), prognostic discussion, impact of treatment on quality of 
life, practical issues and next steps. These variables each have a number of sub-topics 
pertaining to the main variable (Appendix 2.2). 
 
Preliminary topics, developed through the literature review and observation of HSCT 
consultations, were formatted into a draft which was then presented to three 
Consultant Oncologists and the ethics committee from the Beatson as well as the 
academic and expert field supervisors who were from diverse professional backgrounds. 
They explored each topic and corresponding sub topics, content of questions, wording 
and organisation, noting individual merits and flaws of the target population. Their 
suggestions were incorporated into the RUIT and a revised draft was submitted for 
additional feedback. 
 
The recall and understanding interview template (RUIT) was finalised for recording 
and scoring the agreement between information that was conveyed by the consultant, 
and then recalled and understood by the patient. This was subsequently used as a coding 
framework. 
 
Phase 2: pilot study and RUIT refinement 
 
 
The pilot was conducted at the Beatson West of Scotland Oncology Centre (BWoSOC) 
NHS Greater Glasgow and Clyde in Scotland. This cancer centre was chosen because it 
is where the majority of patients requiring HSCT, are referred for consultation. 
 
 
Recruitment 
 
Participants were considered eligible to participate in this study if it was their first 
consultation and they were eligible for HSCT, and were referred consecutively to the 
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Beatson 
West of Scotland Cancer Centre (BWoSOC). Haemato-oncology medical staff working 
with patients undergoing HSCT at the BWoSOC reviewed their database, which 
indicated that approximately 12 HSCT patients would be available for recruitment 
within a six-month period. Participants were eligible for inclusion if they met the following 
criteria: 
 
Inclusion criteria: 
 were candidates for HSCT 
 were at least 18 years old 
 were aware of their diagnosis (e.g. acute or chronic leukaemia) 
 if English was their first language 
 
 
Exclusion criteria. Patients; 
 had severe psychiatric morbidity 
 had problems with substance misuse 
 were unable to provide informed consent 
 
 
Participants’ who were referred for HSCT to the BWoSOC between January 2013 and 
June 2013, and identified as suitable according to the inclusion criteria (Figure. 3) were 
sent an invitation letter with an attached ‘consent to be contacted by researcher form 
alongside their hospital letter for initial clinic appointment. Those interested in taking 
part returned the consent form via a stamped addressed envelope to the researcher. 
Patients were then contacted individually and the process explained in detail. Interested 
participants were then given a participant information sheet, a full consent form and 
relevant pre-consultation questionnaires to complete on the day of their HSCT appointment. 
This process was outlined in the Participant Information Sheet and in the instruction sheet 
included in the questionnaire pack. Five participants expressed their interest in 
participating. 
 
The participants included four males and one female. The mean age at the time of their 
HSCT consultations was 52 years old (range: 34-62 years). Participants were about to 
undergo HSCT for a variety of haematological cancers and were all eligible for HSCT. 
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Two participants were also diagnosed with Myelofibrosis. These participants were 
included in the study as it was decided that this would not affect the homogeneity of 
the sample, given that these individuals were both deemed eligible for HSCT in the future. 
The research aims of this study were therefore still significant for these participants and it 
was decided that their inclusion in the study would add depth to the findings. 
 
Figure 3. Characteristics of participants 
 
 
 
Participant Age Gender Disease type Diagnosed 
1 34 
Male Hodgkin’s lymphoma 2010 
2 53 
Male Myelofibrosis 2008 
3 56 Male Chronic myeloid 
leukaemia 
2012 
4 52 Female Myelodysplastic syndrome 2011 
5 62 Male Acute myeloid leukaemia 
2012 
 
 
Participants and recruitment method 
 
Within qualitative research, sample size is not predetermined so power calculations are 
not appropriate. Quantitative research provides the best opportunity to generalise results 
to the population but the purpose of qualitative research is to gain an in-depth, 
thorough understanding of the meanings that patients attribute to their experience and 
to gain an understanding of their perspective (Barker et al. 2002). In the context of 
this research, it provides an insight into the individuals’ who are required to make 
decisions about HSCT. Instead of placing the elements of a consultation in predefined 
categories, using this qualitative approach, themes were established and based on data 
while coding. Therefore purposive, convenience sampling was used with those who 
met the selection criteria. A sample size of five participants was deemed feasible and 
appropriate, taking into account the referral rate, the time available to recruit participants 
and the range of this research. 
 
Ethics 
 
This study was carried out in accordance with the British Psychological Society’s 
(BPS) Code of Ethics and Conduct (2009). Prior to the commencement of the study, a 
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standard two-step process was undertaken to receive organisational approval from the 
BWoSOC (see Appendix 2.3). Full ethical approval was also obtained from the West of 
Scotland Research Ethics Committee (Appendix 2.4) while management approval was 
also received from the Greater Glasgow and Clyde Research Development (see 
Appendix 2.5). Participants were fully informed about the research aims and procedure 
prior to the collection of their data (see Appendix 2.6). Subsequent ethical approval was 
also obtained to include patients’with chronic leukaemia (Appendix 2.3). Written consent 
for the participation, recording and transcribing of interviews as well as the publishing 
of anonymised quotations, was sought from consultants and all of the participants 
(Appendix 2.7). Each participant was given a number and all personal information 
was removed from the study to ensure anonymity and protect confidentiality. 
Procedure 
 
The medical consultation (approximately 1 hour) was digitally recorded using a digital 
voice recorder (DVR). This was located in the clinic room by the researcher prior to the 
participant and consultant entering the room. Following the consultation, and once the 
participant left the clinic room, the researcher collected the DVR. The researcher then 
interviewed the participant using the RUIT in a separate clinic room. This interview was 
also recorded. Every effort was made to work around patient’s schedules. Consent to 
record the consultation was also sought from the individual Consultant Haemato-
Oncologist. Whilst it can be argued that observing in this way may influence participants 
responses, audio or video recording are considered non-intrusive by nature (Dunn et al. 
2005). The present study used a combination of direct (audio recording) and retrospective 
(semi-structured interviews) observation. Figure 4 shows a preliminary outline of the 
participant’s recruitment and participation in the study. 
 
Data collection 
 
Semi-structured interviews were used to collect data. These were recorded for later 
transcription. Participants’ were firstly invited to freely recall information from their 
consultation and talk as broadly as possible about their memory of the information 
they received from their HSCT consultation. It was made clear to the participants that 
there were no right or wrong answers and there was no expectation that they would be 
able to recall all 
of the information. Clinical skills of active listening, simple reflection and empathy 
were given priority in order to ensure the interview was as patient-centred as 
possible. The transcripts were then transcribed ready for anlaysis by the researcher. 
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Phase 2 (Steps 6-10): Pilot study and 
RUIT refinement 
Step 1: Consent sought from patient 
and doctor to observe clinical 
consultation and take notes 
throughout. 
Step 6: invitation to take part 
 
Mail 30 (n=5) Step 2: Each observed consultation 
transcribed, coded and themed 
using content analysis to create 
draft template 
Step 7: Consultation 
Step 8: Post-consultation 
 
Patient Interview Schedule (using RUIT) completed 
during face-to-face meeting. Step 3: content analysis of literature 
for themes added to content of 
RUIT 
Step 4: RUIT circulated to 
Consultant Oncologists at Beatson 
Step 5: Pilot instrument 
Step 11: Problem solving/Developed codes for 
recall and understanding 
 
Branching sub codes within 3 level structure to 
capture both recall and understanding 
Step 10: RUIT circulated to 
Consultant Oncologists at 
Beatson, Research & Field 
Supervisors for additional 
feedback Step 13 Application of coding to transcribed data 
Transcripts independently coded blindly in pairs by 
field supervisor and academic supervisor & 
compared with RUIT coding framework & 
agreement reached on analysis process 
Step 12: Revised RUIT applied 
to code interview transcripts 
Step 14 Inter-rater agreements 
 
Inter rater agreement obtained (Kappa = 0.83 
p<0.01) 
Step 15: Final template 
Phase 3 (Steps 10-15): Further 
development and validation of 
RUIT 
Step 9: Interviews audited 
 
Research & Field supervisors explored each 
transcript & provided feedback 
Pilot of RUIT with patients attending for 
HSCT 
 
Figure 4. Process to address RUIT reliability and validity 
 
    
Phase 1 (Steps 1-5): Development 
and validation of RUIT 
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Interview schedule 
 
The same interview schedule, based on the RUIT, was used for each patient because 
individual consultations were very similar. The interview schedule was structured into 
two main sections, to elicit both spontaneous and free recall. The questions from the first 
section were open-ended to allow for participants individual interpretations and 
explorations of the key topics of information that they received during consultations 
(e.g. “can you talk me through everything you remember the doctor saying to you during 
your consultation (date)?” and “can you remember anything else?”). These were followed 
up by focused questions to obtain further information about key topics (e.g. did the 
consultant talk with you about your health condition/illness? What do you remember the 
doctor telling you about your health condition/illness?). 
 
All participants were asked the same questions. It was then possible to elicit information 
from participants regarding different topics of information that were typically discussed 
during consultations. Examples are; the status of the disease, treatment options, and aims 
of treatment, donor match, practical issues, side effects, graft vs. host disease (GvHD), 
and prognosis and course of recovery. The researcher continued to ask questions until 
satisfied that the patient was unable to recall any more information. This allowed 
participants to recall as much as they could from the consultation. The semi-structured 
format is considered appropriate to explore individuals’ perceptions of doctor-patient 
communication and the factors which influence this (Carlson et al. 2005). The researcher 
was sensitive to the patients’ use of language and efforts were made to use their own 
words to prevent the researcher’s own interpretations from influencing participants’ 
responses. Patient interviews took between 20-30 minutes, on average, and were 
digitally recorded, uploaded onto the laptop and transcribed verbatim, without making any 
references to people or places. 
 
Research recommends that patients are interviewed immediately after consultations for 
optimal performance on tests of recall (Carlson et al. 2005). However, to reduce the risk 
of overwhelming patients, assessment of patient recall and understanding occurred 
individually with the researcher at a convenient time point between the first and second 
consultation. 
 
Analysis 
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Directed Content analysis was used to code and analyse recall and understanding of 
the communication from the consultation (Carlson et al. 2005) using pre-determined 
categories from the RUIT. This process involved two main preparation steps: data 
scrutiny and data comparison. Data scrutiny consisted of separately evaluating each data 
set; consultation data and interview data to determine key findings in each phase and to 
structure data in a way that would enable comparison. For further information about the 
methods of analysis used in this study, refer to Miles and Huberman (1994). 
 
Transcript auditing 
 
The field and research supervisors audited each consultation and interview transcript to 
ensure accuracy. Whilst this was lengthy process, it was extremely important in allowing 
the researcher and supervisors to gain familiarity with the data and gain confidence in its 
overall trustworthiness. The supervisors subsequently disseminated feedback to the 
researcher and changes to the transcripts format and content were noted and amendments 
made. 
 
Phase 3: further development and validation of RUIT 
 
Similarly, congruence among supervisors and the researcher as well as consultants at 
the Beatson Cancer Centre, regarding identification of further RUIT topics and content 
was also reached and recorded in the researchers field notes (Appendix 3). Following 
discussion, a major change was identified. The first section, ‘information pertaining to 
patients’ current/past health and well-being’ was removed as consultants often elicit this 
information as a means of obtaining a patient’s background. Appendix 3 details a full 
summary of how adjustments were made to the RUIT. 
 
Data scrutiny 
 
A coding sheet was devised for each participant, which contained interview and 
consultation data. The coding sheet comprised of a table, which consisted of each topic of 
the RUIT. Two separate columns were generated into which participant and consultation 
information could be placed after thorough reading of both sets of transcripts. Previous 
examination of the data had resulted in the identification of eight RUIT topics and 50 
sub-topics (Appendix 2.2). Reading the transcribed material through several times, the 
researcher became immersed in the data. Firstly, RUIT topic categories were identified 
on the consultation transcripts on a line-by-line  basis  while  indicating  RUIT  topic  
code  in  the  margins  of  the  transcripts. 
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Similarly, RUIT topic codes were applied to the interview transcripts. This was to capture 
all the possible occurrences of the phenomenon and thereby increase the trustworthiness 
of the coding framework (Hsieh and Shannon, 2005). As the aim of the research was to 
develop a tool worthy of assessing the level of recall and understanding of 
medical/factual information given to patients who attend HSCT consultation, it was 
decided to analyse only the manifest content, that is the factual information given to 
patients during their consultation. 
 
Applying RUIT codes to the data 
 
Figure 6. Example of sentence-by-sentence coding from consultation   
 
 
Consultation transcript text Interview transcript text 
 
Consultant: From then on it’s a case of dealing with 
effects of treatment and dealing with effects of the 
transplant. 1g Idea of the chemo is to suppress your 
Immune System and Bone Marrow it will stop your Bone 
Marrow (BM) working and will 3c take 2/3 weeks for the 
new BM to be working during that time your  blood 
counts going to drop down to very low levels so your not 
going to have white cells in your blood and those are 
important for protecting you from infection.  Platelets 
help your blood to clot. So you won’t have any platelets 
so 3cyou will be at increased risk of infection and you’re 
going to be at increased risk of bleeding. You might need 
blood transfusions and so you’re very vulnerable and so 
you’re looked after in a room in the transplant unit 
specially designed to protect you from infection. During 
the time from transplant – no problem wondering 
around ward but wouldn’t want you leaving the ward 
cause you’re in an 8benvironment that’s designed to 
protect you and keep you safe no problem getting 
visitors as long as they don’t have coughs and colds or 
upset tummies. 
 
4P: He said there would be risk of infection more so in 
first 3 months. But longer you go on less chance of 
infection. You could feel dizzy; vomiting catch coughs 
colds and all these kinds of things. You’re going to feel ill 
more immediately after. Score=1b 
 
 
 
1b = distorted recall 
 
1g =purpose of conditioning treatment 
3c = side effects and risks of HSCT  
8b = practical implications 
 
 
 
 
The headings and relevant content were then collected from individual transcripts and 
added to the relevant columns on the coding sheet (Appendix 3.1). Participant recall 
was subsequently compared to the actual communication in the transcribed audio 
recordings of the consultation based on the RUIT (Appendix 3.2) categories and level of 
recall and understanding. 
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Figure 7. Example coding excerpt from coding sheet 
 
 
2. Explanation 
of treatment 
Category Patient 
transcript 
Consultant 
transcript 
Code assigned 
Patient       able       to 
discriminate how 
HSCT is different from 
previous treatments 
they have had 
B Can have a transplant 
but that would only be on 
condition of the...as he 
said before a suitable 
donor, remission, and 
fitness to take the 
treatment. The other 
option is more  chemo 
that would put it into 
remission for about a 
year or more but it 
wouldn’t offer a cure 
long term. 
not as straightforward as 
recovering from chemo there 
is the potential for a lot of 
hiccups along the way. A 
transplant can cure the 
leukaemia where the chemo 
couldn’t. Issue with transplant 
is that it is a demanding 
process to go through in some 
ways more demanding than 
chemo you had already. 
2 – recoded & 
agreement reached on 
complete recall 
thereon, as participant 
able to distinguish that 
transplant has the 
potential to cure the 
Leukaemia, whereas 
chemotherapy wouldn’t 
in the long term. 
Source: redrawn from Appendix 3.2 
 
 
Data comparison 
 
The second step was data comparison. The researcher used t h e  “contrasting” strategy 
because this is especially suited for comparing two types of material (Boyatzis, 1998) and 
because she already had an idea of the information that should be looked for as a result of 
the RUIT. This involved coding and analysing the level of concordance between 
information given by a Consultant during consultation and an individual patient’s recall 
and understanding, using the RUIT (Appendix 3.2). Coding was developed through 
discussions with the field and academic supervisors as well as with an external supervisor. 
 
Coding recall and understanding 
 
A number of difficulties were apparent whilst coding the data, highlighting the complexity 
of this process. Firstly, it was difficult to differentiate recall from understanding. Recall 
can be considered simply as repetition of information given in the medical consultation and 
does not necessarily imply that the patient has understood the information. For example, it 
is possible to memorise a number or medical term without understanding their meaning. 
Patients generally find it difficult to understand and recall much of what is said in 
consultations, and as such the two are likely to be closely linked (Hacking et al. 2013). A 
rating format similar to that employed in the Rivermead Behavioural Memory Test 
(Wilson et al. 2008) was applied to code both recall and understanding allowing the 
coders to differentiate between errors of commission (e.g. misunderstandings) and errors 
of omission. Sub-codes were devised from the following 3 level structures: 
 
2 = complete; 1a = partial recall, 1b distorted recall; 0a = omission, 0b = fabrication/intrusion 
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Subsequent to data preparation and organisation onto the coding sheet, an additional 
column was added (Figure 3) entitled “code assigned”. Investigator triangulation, 
utilising a second investigator to analyse some of the data and compare findings, facilitated 
the coding process. The above ratings were applied to consultation transcripts for 
participants one, three and five by the field supervisor and the academic supervisor coded 
the transcripts for participants two and four. The researcher coded transcripts for all 
participant interviews and consultations. Initially, similarities and differences in rating 
application were discussed whilst reading transcripts and team coding in real time. 
 
During team coding, the researcher read through transcripts together with the research 
and field supervisor and recorded in the margins of the transcript the presence of topics, 
associated items and the level of recall and understanding. Once each coder was able to 
create their own example of coding each topic, this was then shared with other coders until 
consensus was reached regarding each code and sub code. Finally, the researcher coded 
all transcripts and the field and research supervisors coded a proportion of transcripts. 
This allowed the calculation of inter-rater agreement regarding codes applied. In total, the 
process of triangulating coders between the researcher and the field and academic 
supervisors occurred on 3 occasions. During each meeting the academic supervisor and 
the researcher independently coded an audited transcript and notes were made and 
discussion about the application of codes occurred. The congruence or differences of the 
process were recorded by the researcher in field journal. 
 
Challenges of coding 
 
Mapping participant interview information onto consultation data was a complex process 
that required moving back and forth between the two data sets. There were a number of 
difficulties encountered during this process. For example, some participants used 
colloquial terms rather than the medical terminology used by consultants or the 
researcher. In addition they did not necessarily recall information verbatim from their 
interview in the order it was prompted and in the way used by their consultants or the 
RUIT interview schedule and by the researcher. Therefore, application of the codes to 
determine the accuracy of recall and understanding required the raters to make 
interpretations, which may have been confounded by their subjectivity. Although this 
resulted in disparity of how codes were applied, the raters discussed each instance of 
coding for elucidation and/or clarification until saturated. At this point agreement was 
reached and/or disagreements were recorded in field notes. Agreement was facilitated 
because of the researchers close relationship with the data, through constant comparison 
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of the information and knowledge of the participant’s emotions and body language as 
recorded in field notes. It could be argued therefore that through this process, 
consistency of applying the ratings emerged and this enhanced the validity of the RUIT. 
For the purposes of transparency, comments to the coding column, as depicted in 
Appendix 3.2, have been added describing the process of agreement among coders. To 
enhance the transparency of the coding process, detailed instructions describing the 
application of the coding system and categories can be found in Appendix 3.3. 
 
Results 
 
Inter-rater agreement 
 
 
In the final, RUIT eight categories, with 50 sub-categories of information, were included. 
The researcher scored the transcripts according to the coding system and the field and 
academic supervisors also scored a proportion of the transcripts. An inter-rater reliability 
analysis was subsequently performed using Cohen’s Kappa for each code using Landis and 
Koch’s (1977) classification 0.21–0.40, fair agreement; 0.41– 0.60, moderate agreement; 
0.61–0.80, substantial agreement; 0.81–1.0, near-perfect agreement. Kappa statistics 
demonstrate the degree to which two or more raters agree that the coding system measures 
target variables (8 topics contained in RUIT), in this instance the patient’s level of recall 
and understanding of the RUIT topics. The resulting index compares the recorded 
agreement with that expected by chance. 
 
The following formula was used:   where n = number of subjects, na = number 
of agreements and nε = number of agreements due to chance. 
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Figure 8. Inter-rater agreement for coding system for RUIT framework 
 
 
RUIT topic Inter-rater 
agreement 
Explanation of treatment process 0.67 
Aims of treatment 0.55 
Side effects of treatment 0.95 
Graft vs. Host Disease 0.88 
Prognostic discussion 0.83 
Impact of treatment on QoL 0.82 
Practical issues 0.95 
Next steps 1.0 
Overall inter-rater agreement 0.83 
 
There was moderate agreement, among raters for the aims (Kappa=0.48, p<0.01) and 
explanation of treatment (Kappa=0.67, p>0.01) topics of the RUIT. There was 
substantial agreement subsequently for the remaining topics indicating that the RUIT 
coding sytem was consistent in its application across topics: side effects of treatment 
(Kappa = 0.95, p<0.01) graft vs. host disease (Kappa=0.876, p<0.001), prognostic 
discussion (Kappa=0.829, p<0.001) impact of treatment on quality of life (QoL) 
(Kappa=0.815, p<0.001), practical issues (Kappa=0.95, p<0.01) and next steps 
(Kappa=1.0, p<0.01). 
 
Overall inter rater agreement was calculated as the mean of the inter-rater agreement 
scores for all categories on the RUIT and served as an index of content validity 
(Kappa=0.83, p<0.01). A more substantial breakdown of inter-rater agreement of topics 
and subtopics of the RUIT can be found in the appendix (appendix 3.4). 
 
 
Results part two: participant reflections of the consultation 
 
Some participants openly reflected about the consultation. Their reflections included; 
comments about the consultation length, consultant’s communication style and 
emotional reactions associated with the content. 
 
 “I think he was pretty comprehensive in what he had to say but taking it all in for the last 
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10 minutes or so I turned off deliberately. So thought had enough of this because to large 
extent it’s doom and gloom. It’s not that I don’t want to be knowledgeable but at the end 
of the day it’s just that’s what I found” (Participant 5a) 
 
This participant admitted consciously filtering out negative information (e.g. risk of 
mortality) relating to the prognostic information. The quotation not only emphasises 
the apprehension associated with hearing life-altering information, but also this 
participant’s need to protect himself from the potential negative impact on his mood. 
 
“The only thing I would say is that it was an hour, which I was expecting, but an hour of 
full- on information really, without time to stop and think, and think whether there’s 
anything you want to ask relating to that. Although, with respect, at the end when I 
looked at my list of questions everything had been covered, but it’s just that it’s all very 
much funnelled into one hour and it’s a whole load of information to take on board 
without time to think about it, maybe in stages.” (Participant 4a) 
Another participant commented on the length and structure of the consultation. This 
quotation suggests that the participant struggled to retain the information given to them, 
and sought a more interactive style of communication from the consultation. Similarly, 
another participant also expressed that the information was “quite hard to take in” 
(Participant 3a).  
 “The words ‘death’ and ‘life threatening’, obviously, you’re going to feel, I could feel 
my stomach churning a little bit.” (Participant 3b) 
 
Similarly, another participant described the life threatening information given during 
the consultation left him feeling anxious. It is evident from this quotation that the 
participant’s initial expectations were not met and therefore, added to his apprehension, 
was a sense of disappointment. 
 
“And I do think you need someone writing it down, which he did (participant’s 
husband) cause I think if you were in on your own and trying to assimilate all that 
information and remember it all it would be difficult, whereas you can go back and look 
at some of it...You should give us a copy of this was what she actually said so that you 
can listen to it again afterwards.” (Participant 5b) 
 
Finally, one participant also reflected on their information requirements, stating that the 
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use of information aids would aid their recollection of information from the HSCT 
consultation. This participant further recommended the use of an audio CD, which she 
could then listen to at her own leisure, to facilitate her recollection of the information given. 
 
Summary 
 
 
Application of the recall and understanding coding system to RUIT topics among 
coders revealed discrepancies in the classification of information. Results show two 
categories; explanation of treatment process and aims of treatment, which did not meet 
substantial agreement. It is not known whether discrepancies within categories that did 
not meet these criteria were either lacking clarity in their description or other factors related 
to the patient or doctor may have influenced the communication and interpretation of 
information given to the participant during HSCT consultation. 
 
Discussion 
 
The purpose of this research was to develop a coding framework for measuring the 
interaction between doctors and their patients who are about to undergo HSCT transplant 
for leukaemia or other blood disorders. This study has reported the development and 
testing of a coding framework, the RUIT template and coding system, and in doing so, 
elucidated the methodological issues and some of the challenges of conducting research 
in the haemato- oncology setting. The procedures undertaken in developing the RUIT 
demonstrate reliability and content validity. Further testing through piloting the instrument, 
indicated that the RUIT coding system has strong inter rater agreement. 
 
Factors influencing the interpretation of the communication 
 
Kessels (2003) reported that 40-80% of medical information presented to patients by 
health care professionals was immediately forgotten by patients. These figures were 
influenced by a combination of consultant and patient factors, including the use of 
medical terminology and patient’s emotional state, older age or cognitive difficulties. In 
addition, if they had previously received treatment for cancer, this may have resulted in 
cognitive impairment (Friedman et al. 2009). Thus, many variables, including both 
consultant and patient iatrogenic 
factors, can influence doctor-patient interactions. Within the field, however, research 
has predominantly focussed on consultant communication skills and their impact on patient 
satisfaction more generally. Multiple studies have shown that patient characteristics as 
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well as a doctor’s style of communication influence the communication and 
interpretation of information given to patients during cancer consultations (Thorne et al. 
2005; Hack et al. 2005; Hagerty et al. 2005; Butow 2000; Fagerlind et al. 2012). 
 
Clinician characteristics 
 
 
Whilst communication skills training has broadened to incorporate shared decision 
making, information exchange, enhancing the doctor patient relationship and responding 
to the emotional tone of the consultation, there remains a need for health care professionals 
to tailor information giving to meet individual patient’s needs (Jenkins et al. 2011). 
However, difficulties in communication can arise as a result of differences in goals 
among health professionals and patients. 
 
Compassion fatigue, and diminished empathy may result in clinicians ‘burning out’, with 
a negative impact on their ability to deliver information in a patient- centered way (McLean 
et al. 2011). The authors concluded that the psychological state and predisposition 
towards optimism of both doctors and patients might influence the communication and its 
interpretation. The findings of this study are consistent with previous research suggesting 
that both healthcare professionals and the patients are influenced by pre-existing attitudes, 
systemic and cultural beliefs and values as well as by their friends and family 
members (Carlson et al. 2005). For the population under investigation, a family member 
accompanied almost all participants to their consultation for HSCT. The needs of 
family members and carers interact with the needs of patients. Although not considered in 
Feldman-Stewart et al.’s (2005) framework, they were apparent in the narratives of the 
population under investigation. 
 
 
Patient characteristics 
 
It was clear that participants experienced anxiety during their consultation and reported 
actively “switching off” at points to avoid experiencing the associated “doom and 
gloom”. Patients with advanced cancer often experience strong emotions such as sadness, 
anxiety and fear throughout the course of their illness (Derogatis et al. 1983), which can 
cause a loss in memory function (Blaney, 1986) and impact adversely upon the patient’s 
ability to recall information given during cancer consultations (Carlson et al. 2005). 
Specifically, Kizilbash et al. (2002) reported that depressive symptoms (with or 
without anxiety) have a negative impact on the ability to immediately recall new 
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information but not on the retrieval or retention of information. 
 
 
Anxiety can both inhibit or facilitate recall and understanding of information given 
during medical consultations. Kessels (2003) explains this phenomenon in terms of 
“attentional narrowing”. This occurs when information or events perceived as aversive 
(e.g. side effects of treatment), become the primary focus of attention. This may cause 
anxiety and limit the patient’s attention towards information they perceive as being less 
important, allowing them to “focus on” salient pieces of information and thereby 
experience an enhanced memory of it. Information perceived as upsetting may cause 
patients to become overwhelmed, and this may impact adversely on their ability to 
cognitively process information that they receive during consultations. Patients may believe 
that they lack information, consequently causing feelings of uncertainty, anxiety and 
depression (Ong et al. 2000). Both very high and low levels of anxiety can lead to lower 
recall of information, with moderate levels resulting in optimal performance in tests of 
recollection (Ley, 1988). 
 
 
Two participants also commented on the length, content and structure of the 
consultation, stating that the volume of information given was difficult to process. A 
comprehensive review of the literature (Fallowfield and Jenkins, 1999) revealed, in 
several ways, good evidence that the structure and content of the consultation influences 
the patient's ability to remember what has been said, in the following ways: 
 
1) Patients usually recall facts provided at the start of a consultation more readily 
than those given later; 
 
2) Topics deemed most relevant and important to the patient (which might not be 
those considered most pertinent to the doctor) are recalled most accurately; 
 
3) The higher  the  number  of  statements  made  by  a  doctor,  the  smaller  the  
mean percentage recalled by the patient; 
 
4) Items that patients do manage to recall do not decay over time, as do other 
memories. In fact, many patients have verbatim recall of what they believe the 
doctor to have said. 
 
 
On the other hand, research demonstrates that cancer survivors who have received 
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radiotherapy and chemotherapy can experience impaired memory as a consequence of 
these treatments (Joly et al. 2011). Asher’s (2011) review of cognitive dysfunction among 
cancer survivors reported that individuals’ with acute leukaemia and myleodysplastic 
syndrome can experience impairments before treatment, including deficits in memory and 
learning, processing speed, aspects of executive functioning and upper limb dexterity. This 
review also suggests that cognitive impairment may also be explained by anxiety, 
depression and fatigue which are common symptoms experienced by the cancer population. 
 
 
Clinical implications 
 
 
The results of this research have implications for clinical practice, especially in relation to 
the involvement of patients in their preference for information about HSCT. Through 
developing and piloting the RUIT and coding system, it was apparent that clinicians did 
not consistently convey the psychological impact of HSCT. This finding was 
disappointing given that the literature pertaining to communication goals and the needs 
of cancer patients suggests that cancer treatment outcomes are enhanced when health 
professionals attend to the emotional needs of their patients (Fagerlind et al. 2008, 
Thorne et al. 2005), and are facilitated by the use of empathic and informative language 
(Butow et al. 2000). This is of particular importance in relation to the population under 
investigation, given the often intense emotional experience associated with life-threatening 
conditions and treatment (Rodriguez et al. 2010) and increasingly in the context of the 
provision of HSCT related information and support becoming the role of clinical nurse 
specialists (Rood et al. 2014).  
 
In overcoming such barriers, for example, doctors could use the RUIT tool to plan 
the structure and content of the consultation. This would allow doctors of varying clinical 
expertise and clinical nurse specialists within NHS Greater Glasgow & Clyde (NHS GG 
& C) to use the RUIT to provide additional information onspecific topics, as an aide 
memoire in clinical practice.  
During their interviews, participants reflected on the structure and content of sessions 
in relation to remembering and understanding the information from the consultation, in 
particular, the large amount of information provided, medical terminology used, length of 
the session and opportunity to ask questions throughout the consultation. These results 
support the findings of Rood et al. (2014) who found that patients with haematological 
malignancies vary in the amount of information they require and that basic information, 
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tailored specifically to their needs, on diagnosis, treatment, prognosis and other topics may 
be all that is needed to meet their informational needs.  
 
For example it is possible that the RUIT could be used post consultation by the nurse 
specialist to check and clarify patient understanding of information about HSCT. This would 
benefit patients and the service alike giving opportunity to correct any potential 
misunderstandings. Using the RUIT in this way would create a culture within the Hemato-
oncology setting whereby nurse specialists could ensure that the correct information was 
given to patients but also educate the patient on HSCT. This could be formalised into an 
intervention implemented by a nurse navigator (Thygesen et al. 2011) and its effectiveness 
investigated more rigorously through a randomised control trial.   
  
Limitations 
 
 
To reduce the possibility of biasing the results, as is frequently the challenge in 
qualitative research, the research design and outcomes were mapped against Guba and 
Lincoln’s (1994) trustworthiness criterion for qualitative research. The research strategies 
and operational techniques to achieve auditability, transferability, credibility and 
confirmability have also been detailed. 
 
The researcher acknowledges she undertook multiple roles as part of this research. 
The researcher fulfilled the role of interviewer, coder and principal investigator, with the 
potential to bias interpretation of findings. However, systematic bias was countered 
through auditing transcripts, member checking and triangulation. Validity was maximised 
through investigator triangulation, whereby the field and research supervisors coded and 
analysed all transcripts, discussing, and comparing until agreement was reached or 
disagreements recorded regarding the codes applied, thus enhancing ‘trustworthiness’ in the 
findings. In terms of transferability it has been proposed that consideration of the findings 
can be left with the reader to decide which aspects of the case apply in new contexts; 
therefore it is the reader not the researcher that makes the generalisation (Lincoln and 
Guba, 1994). 
 
A consultant clinical psychologist specialising within oncology, who is also an experienced 
field supervisor oversaw the validity of the RUIT coding framework and process of analysis. 
Feedback regarding the RUIT framework was also gained from experienced consultants 
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within the field of HSCT and the content was subsequently revised prior to and after the 
RUIT was piloted. Experienced research supervisors guided the development of the coding 
and classification system. Validity could also have been strengthened through data source 
triangulation, for example by combining participant data with consultants’ predictions of 
participant recall and by understanding or by surveying topics of information imparted to 
them about HSCT, that are of most significance and by comparing both sets of information 
(Jenkins et al. 2011). Credibility in the findings could also have been enhanced through 
actively seeking participant views about their involvement in the study, and participation in 
the interview itself. 
 
Conclusions 
 
 
This study demonstrates the complexity of designing, refining and implementing a tool 
to measure patient recall and understanding of the HSCT consultation, based in an 
outpatient haemato-oncology clinic at the Beatson Oncology Centre in Glasgow. It is 
also the first qualitative investigation of patients’ recall and understanding of content from 
a HSCT consultation using the RUIT tool. 
 
The criteria developed by Guba and Lincoln’s (1994) describes the procedures undertaken 
in developing the tool to demonstrate rigour through ensuring inter-rater reliability, and 
content validity. The pilot study further indicated that the RUIT is highly reliable and 
has internal consistency. However, upon a closer inspection of the individual RUIT 
categories 2 topics did not meet substantial inter-rater agreement. The process of 
generating a tool that demonstrates truthfulness, credibility, auditability and 
conformability for surveying patient recall and understanding in the context of HSCT 
consultations, may help to identify the information needs of patients, using a reliable 
means. 
 
Throughout the pilot of the RUIT participants also told of their experiences of the 
content, and structure of the HSCT consultation as well as the communication 
behaviours’ of the consultants’. An awareness of patient opinion regarding the 
consultation may enable services to ally themselves with the patient, providing accurate 
and relevant information, where possible. This investigation provides an initial summary of 
the development and validation of a tool to measure doctor patient communication in the 
haemato-oncology setting which points out the necessity to distinguish aspects of the 
consultation that are easily misunderstood so that support can be planned that may help 
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patients’ to remember and understand information given to them during consultation. In 
doing so, services can best attempt to meet the informational needs of haematological 
patients’ in a personalised manner. 
 
Implications for future research 
 
 
To obtain a better understanding of haematological patients’ recall and understanding 
of HSCT consultations, future studies will require to consider the following: 
 
- Firstly the interview schedule will require some adjustment to match the RUIT 
categories and be re-piloted to strengthen reliability and validity. For items on the 
RUIT that did not meet the criterion, they may require elimination or modification to 
increase clarity for future use in such research; 
 
- Secondly, future research may focus on measuring recall only for the 'important 
points' of the consultation and asking both patients and doctors what those points are; 
 
- Finally, some researchers have suggested that verbatim recall does not necessary 
result in understanding and sometimes, and for certain types of information, knowing 
the 'gist' is good enough or better (Jansen, 2008). Researchers, therefore, might ask 
oncologists to summarise the most important points that were discussed in each 
consultation and make a tailored recall questionnaire based on that information 
(Jenkins et al. 2011). As such, future research may focus on devising a tailored 
questionnaire based on the items discussed rather than using the same RUIT interview 
for each consultation. 
 
Future research may also employ a mixed methods correlational study design, with a 
larger sample that may add to our understanding of the links between psychosocial factors 
and the level of patient recall and understanding. Comparing the use and experiences of 
information aids (e.g. audio CD of consultation) with no intervention, with prospective 
HSCT patients’, would also, perhaps, provide a more definitive argument for the 
effectiveness of information aids with patients about to undergo HSCT. In addition to 
this, a significant other person accompanied all patients and it may also be useful to 
include them in such future research. 
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CHAPTER THREE 
 
 
 
ADVANCED PRACTICE I – REFLECTIVE CRITICAL 
ACCOUNT 
 
 
 
“Connecting the dots” - The development of core therapeutic skills: 
A Reflective Account 
 
 
 
ABSTRACT 
 
Working as a reflective clinical psychologist is considered a core competency of the profession. Hence 
the emphasis placed on doctoral training programmes to facilitate this practice both during and post 
qualification. In line with these requirements the present reflective account is a representation of my 
learning and development during training. The present account focuses on the development of my 
communication and clinical skills within differing settings through the use of three consecutive 
learning experiences. Specifically these experiences emphasise how my skills in applying and 
communicating evidence based psychological knowledge, theories and skills have evolved throughout 
training and future intentions in continuing to do so are interspersed throughout the account. In 
particular this account attends to my reflections of integrating psychological models rooted in systemic 
and attachment approaches. I have used Rolfe’s model (2001) of reflection as well as others that are 
developmentally (Stoltenberg et al. 1998) and systemically (Hawkin’s and Shohet, 2012) based, also 
taking into consideration wider ethical and policy related factors that have impacted upon my 
professional understanding and development.  
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CHAPTER FOUR 
 
ADVANCED PRACTICE II – REFLECTIVE CRITICAL 
ACCOUNT 
 
The multi-faceted role of the clinical psychologist in the Multi-Disciplinary  
Team (MDT): A Reflective Account 
 
 
 
ABSTRACT 
 
Contrary to my first reflective account, which focused on the application of my clinical skills, this 
second reflective account provides a description of my experiences on my placement fulfilling training 
and consultancy roles as well as supporting others in the delivery of psychological interventions as 
part of the Clinical Psychologist’s role whilst working in Psychiatric Rehabilitation in my 3rd year. I 
also attempt to give a rationale for these roles of the clinical psychologist in the context of increasing 
access to psychological therapies in Scotland. I have used Rolfe et al.’s (2001) model of reflection 
embedded within Hawkins and Shohet’s ‘Seven Eyed’ supervision model (2006) to guide my 
reflections of this experience. 
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Appendix 1.1: Excluded papers following inclusion/exclusion criteria 
 
 
Reference Reason 
McJannett, M., Butow, P., Tattersall, M., & Thompson, J. (2003). 
Asking questions can help: Development of a question prompt 
list for cancer patients seeing a surgeon. European Journal of 
Cancer Prevention, 12(5), 397-405. 
Includes views of 
health professionals as 
well as patients 
Iredale, R., Rapport, F., Sivell, S., Jones, W., Edwards, A., Gray, J., 
 
& Elwyn, G. (2008). Exploring the requirements for a decision 
aid on familial breast cancer in the UK context: A qualitative 
study with patients referred to a cancer genetics service. 
Journal of Evaluation in Clinical Practice, 14(1), 110-115. 
Patients are at risk of 
Breast cancer no 
diagnosis 
Korber, S. F., Padula, C., Gray, J., & Powell, M. (2011). A breast 
navigator program: Barriers, enhancers, and nursing 
interventions. Oncology Nursing Forum, 38(1), 44-50. 
English not first 
language for 1 person 
in sample 
Shepherd, S. C., Cavers, D., Wallace, L. M., Hacking, B., Scott, S. 
E., & Bowyer, D. J. (2012). 'Navigation' to support decision 
making for patients with a high grade brain tumour. a 
qualitative evaluation. Neuro-Oncology, 14, 4-4. 
Abstract/poster for 
conference 
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Appendix 1.2: Quality Rating Form 
 
 
 
 
 
Stage 
 
 
 
Essential criteria 
 
 
 
Present 
 
 
 
Absent 
 
Scope and 
purpose 
 
- Clear statement of focus for research 
- Rationale for research 
- Questions/aims/purpose 
- Study thoroughly contextualised by existing 
literature 
  
Design - Method/design apparent 
- Above consistent with research intent 
- Rationale given 
- Data collection strategy apparent 
- Data collection strategy appropriate 
  
Sampling 
strategy 
- Sample and sampling method explained 
- Above justified 
- Above appropriate 
  
Analysis - Analytic approach explained 
- Above appropriate 
- More than one researcher involved if 
appropriate 
- Participant involvement in analysis 
- Evidence  of  data  saturation/discussion  or 
rationale if did not 
  
Interpretation - Context described 
- Context taken account of in interpretation 
- Clear audit trail (sufficient so others can follow 
decision trail) 
- Data used to support interpretation 
  
Reflexivity - Researcher reflexivity demonstrated   
Ethical 
dimensions 
- Ethical approval granted 
- Documentation of how consent was managed 
- Documentation  of  how  confidentiality  and 
anonymity were managed 
  
Relevance and 
transferability 
- Relevance and transferability evidence 
- Links to theories and literature 
- Limitations/weaknesses outlines 
- Outlines further directions for research 
  
Notes: 
 
Quality Rating Criteria (redrawn from Walsh & Downe, 2006) 
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For more details access:
 http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365- 
2354/homepage/ForAuthors.html
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Appendix 2.1 Reliability and validity of Interactional Analysis Systems (IASs) 
 
Tool Authors What does it 
measure? 
Methods of 
evaluation 
Inter-rater 
reliability/validity 
What is analysed? Special notes 
Cancer- 
specific 
Interaction 
Analysis 
System   (CN- 
LOGIT) 
Butow et al 
(1995) 
Interaction of 
cancer patients and 
oncologists. 
Coding content & 
mood of each 
utterance 
Computerized 
interactional 
analysis  of 
transcriptions of 
audio- taped 
interactions; 
retains sequence 
of events 
Inter-rater reliability 
0.70–1.00 
 
Face validity has been 
demonstrated; convergent 
validity measured (no 
correlation with patient 
satisfaction found) 
Verbal  content,  mood  & 
non verbal behavior 
Required extensive analysis 
of transcripts; coders must be 
trained 
MIPs Global 
Scale 
Ford et al 
(2000) 
As above As above Ranging from 0.88 to 
0.94 
Verbal  content,  mood  & 
non verbal behavior 
Requires extensive analysis 
of transcripts: coders must be 
trained 
Roter 
Interaction 
Analysis 
System 
(RIAS) 
Roter & Larson 
(2002) 
As above Coding directly 
from audio or 
video tape 
0.85 (mean) Verbal & non verbal 
behavour 
Coders must be trained 
 
Coding is performed in real 
time 
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Observer- 
checklist 
Simonoff  et  al 
1989 & 1991 
Treatment related 
topics initiated by 
doctor or patient or 
Coding  directly 
from audio or 
0.88. validity could not be 
retrieved 
Verbal behavior only Influence of observer 
 
Generalizability limited to 
 (OC)  lack of video tape   breast cancer population 
Physician 
behavior 
checklist 
(PBCL) 
Blanchard  et  al 
(1983:1988: 
1996) 
Oncologist 
behaviours  during 
brief  doctor- 
patient encounter 
(rounds) 
Coding directly 
from audio or 
video tape 
Ranging from 0.85 to 
1.00. validity could not be 
retrieved 
Verbal and non verbal 
behavior 
Requires observer to code in 
real time 
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Appendix  2.2:  Recall  and  understanding  information  template  (RUIT)  
framework Version 1.1 
1. Treatment 
 
Explanation of process: 
a. indications  for  VUD  transplant  –  suitability  of  illness  type/stage,  age,  
donor availability, disease in remission (BMA), fitness. 
b. How is a VUD transplant different from previous treatments may have received? 
c. Tests required pre-transplant and reasons for these – heart, lung, kidney, liver 
d. Finding a suitable matched donor, VUD or sibling 
e. Notice period for donor. Likely transplant dates 
f. Stem cell harvesting – how this happens, how much is needed 
g. Conditioning treatments – reduced intensity/Myeloblative; what agents are used, 
over what period of time 
h. What happens – IV transfusion of cells through Hickman line 
i. Anticipated length of hospital admission – indications of when suitable for discharge 
 
2. Aims of treatment 
a. explanation of purpose and intention of transplant 
 
3. Side-effects of treatment 
 
Acute effects 
a. what to expect – week 1, weeks 2-3, week 4-5 
including following: high temperature, rash, rigors, mucosistis, stomach/abdominal pain, 
diarrohea, nausea/vomiting, fatigue, hair loss, reduced concentration/memory, increased 
infection risk 
 
 
b. side-effects of steroids – lose muscle, gain fat, increased BP etc 
c. estimation of length of time takes for immune system to recover 
d. risk of complications diminishing over time 
Late effects 
e. endocrine, cardio-vascular, secondary cancers, fertility, loss of libido, cataracts 
f. how these are screened for and managed – i.e. late effects clinic 
108 
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g. preventative behaviours – stop smoking, high factor sun protection, bowel screening 
 
4. Graft vs. Host Disease (GvHD) 
Acute GvHD 
a. what is it/why does it happen? 
b. Grading 
c. Symptoms – skin, liver, gut, appetite etc 
d. Chances of acquiring acute GvHD – mild, moderate, severe 
e. How this is prevented/managed 
f. Implications of GvHD 
g. Graft vs. Leukaemia Effect – explanation and implications 
 
Chronic GvHD 
h. symptoms 
i. management 
 
5. Prognostic discussion 
establish what information the patient requires 
a. treatment related mortality 
b. relapse 
c. disease free survival 
d. estimation of morbidity/mortality without transplant 
 
6. impact of treatment of quality of life 
a. psychological 
b. social 
c. financial/vocational 
 
7. practical issues 
a. named consultant/team approach 
b. clean environment – issues around visitors, young children, single room, 
infection control – aprons, hand gel 
c. relative overnight accommodation 
d. transport 
e. donor lymphocyte infusion 
108 
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f. long-term anti-microbial therapy 
g. change of blood group 
h. re-immunisation 
i. sperm banking 
j. possible need for re admission 
k. friends of the Beatson 
l. outpatient follow up arrangements 
m. support needs post discharge 
 
8. Next steps 
a. consent form – read over 
b. have a look around the unit 
c. read over booklet before next appointment 
d. take bloods 
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Appendix 2.3 West of Scotland Research Ethics Approval (Amendment) 
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Appendix 2.4: NHS Greater Glasgow and Clyde Research and 
Development Management Approval 
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Appendix   2.5 NHS   Greater   Glasgow   and   Clyde   Research   and   
Development Management Approval 
 
 
Dear Dr Wilson, 
 
R&D Ref: GN12CP481 Ethics Ref: 12/WS/0310 
Chief Investigator: Dr Sarah Wilson 
Project Title: An exploration of the recall and understanding of information given during 
a consultation with Haemato-Oncologist, of patients who are due to undergo 
Voluntary/Unrelated Donor (VUD) transplant for acute leukaemia. 
Protocol Number: Version 3.1 - 22/05/2013 
Amendment: Substantial Amendment 1 (22.05.2013) 
Sponsor: NHS Greater Glasgow and Clyde 
 
I am pleased to inform you that R&D have reviewed the above study's Amendment and 
can confirm that Management Approval is still valid for this study. 
 
Reviewed 
Documents: 
Version Dated Rec'd 
REC Favourable Opinion Letter 
No 
Version 
31/05/2013 31/05/2013 
Notice of Amendment 
IRAS 
v3.5 
22/05/2013 22/05/2013 
MRP Proposal V3.1 22/05/2013 22/05/2013 
 
I wish you every success with this research project. 
 
Yours sincerely, 
Dr Nathaniel Brittain 
Academic Research Coordinator 
NHS Greater Glasgow and Clyde 
Research and Development Central Office 
Tennent Institute 
38 Church Street 
Glasgow 
G11 6NT 
 
Tel: +44 (0)141 211 8544 
nathaniel.brittain@ggc.scot.nhs.u
k  www.nhsggc.org.uk/r&d 
 
Please note that I do not work Fridays 
 
Cc: Shehnaz Iqbal, Trainee Clinical Psychologist, Gartnavel Royal Hospital 
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Appendix 2. 6 Participant Information Sheet 
 
 
 
Factors Influencing Patient Recall and Understanding of Haemato-Oncology 
Consultations: An exploratory study. 
 
 
 
 
 
 
 
 
Participant Information Sheet 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Correspondence to: 
Shehnaz Iqbal 
Trainee Clinical Psychologist Mental 
Health and Wellbeing 
1st floor, Administration Building 
Gartnavel Royal Hospital 
1055 Great Western Road GLASGOW 
G12 0XH 
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FACTORS INFLUENCING PATIENT RECALL AND UNDERSTANDING 
OF HAEMATO-ONCOLOGY CONSULTATIONS 
 
Participant Information Sheet 
 
 
Introduction 
My name is Shehnaz Iqbal and I am a Trainee Clinical Psychologist studying at the 
University of Glasgow. I would like to invite you to take part in a research study. This study 
will be undertaken as part of a doctorate degree. Before you decide if you would like to take 
part, it is important for you to understand why the research is being done and what it 
will involve. Please take the time to read the following information carefully and feel 
free to discuss it with others if you wish. 
 
Please ask me any questions you have. You can phone me on the following number (0141 
301 7324) or you can leave a message and I will get back to you as soon as possible. 
What the study is about 
 
This study  is an exploration of the factors which influence people’s remembering and 
understanding of the information they receive during medical consultations. I am interested in 
understanding the factors that might influence how much information you can remember, and 
the types of information you forget after your hospital consultation about bone 
marrow transplant (BMT). This type of research might help to identify factors that 
influence recall and understanding of medical information, and help us to think of 
ways we could help patients gain as much as possible from their appointments. 
 
Why you are being asked to participate 
 
We are asking adults with acute leukaemia who will be attending the Beatson West 
of Scotland Cancer Centre for their first bone marrow transplant consultation to take part in 
this study. You are being invited to participate because you are due to attend the BMT 
clinic in the near future. 
Do I have to take part? 
 
No. You do not have to take part in this study. It is up to you to decide whether or not 
you wish to participate in the study. If you decide to take part you will be asked to sign a 
consent form. The consent form is a way of making sure that you know what you have 
agreed to. If
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you decide to take part you are still free to withdraw from the study at any point in time. If 
you decide to withdraw from the study, this will not affect your on going medical care in any 
way. 
Taking part in the study – what will I have to do? 
 
If you decide to take part, I will arrange to meet with you on two occasions; before and 
after your medical appointment at the Beatson West of Scotland Cancer Centre. Prior to 
your medical consultation, I will meet with you to explain what you are consenting to, and 
if you are happy to proceed, ask you to sign the consent form. You will be providing 
consent to agree to have your medical consultation and subsequent interview with me 
recorded (to make sure that I carefully understand your experiences, the conversations 
you had with your consultant, and help me remember all the things we talked about). 
The interview after your medical consultation will last for a maximum of 30 minutes. 
During this meeting I will ask you questions about the information you received about your 
transplant. There are no right or wrong answers, the research just wants to learn more about 
your own experience of the types of information you remember and understand from your 
consultation. If you would prefer to discuss this in the form of a telephone interview, then 
I will arrange a suitable time to call you. Our conversation will be recorded using a 
telephone recording device. With your permission, anonymous quotes of what you have 
said may be used in the report. 
Is there a down side to taking part? 
 
It is possible that our meeting may cover topics that are difficult or upsetting to talk about. 
However, if you do not want to continue, you can end the interview, or have a break, at 
any time. If you feel upset at all following the interview, I will be available to talk with 
you. Alternatively, the department’s Consultant Clinical Psychologist, Dr Christopher 
Hewitt, will also be available to talk with you. For participants who decide to have a 
telephone interview, I will pass on the contact details of Dr Christopher Hewitt should 
you wish to seek further psychological support. 
What are the possible advantages of taking part? 
 
There may be no direct benefit to you from participating in this study; however the 
information you provide may be helping others in the future. The information that we learn 
from the study might help us to understand more about the things which influence how 
people remember and understand information given to them about their transplant, and 
may influence how we provide such information to BMT patients. If there are particular 
things that you are unable to remember during our meeting, with your consent, I would be 
able to 
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pass this onto the medical team, so that they can be sure to discuss this with you at your next 
appointment. 
 
Will my taking part in this study be kept confidential? 
 
Your Consultant Haemato-Oncologist at the Beatson will know that you are taking part in the 
study. However, everything that you say during our interviews will be kept strictly 
confidential and no-one but myself will have access to the recordings of the interviews. All 
interview recordings will be destroyed after being transcribed and analysis completed. 
Your name, or other identifying information will not appear in any reports or publication 
from this study. 
 
 
Are there any circumstances when information shared by me during the 
interview would not be kept confidential? 
Everything you say during the interview will be kept private. However, if you tell 
me anything that suggests that you or anyone else is at risk of harm, then it is my duty to 
share this information with other appropriate professionals. 
 
What will happen to the results of the research study? 
 
I will provide you with a summary of the results of the study. The final results and 
conclusions of the study may be published in a scientific journal and will form part of my 
qualification in Clinical Psychology. Your identification will not be included in any 
publication. 
 
Who is organising and funding the research? 
 
NHS Greater Glasgow & Clyde is the Sponsor for this study and there is sufficient funding 
available for the researcher to carry out this research. 
Who has reviewed the study? 
 
The study has been reviewed by the Department of Psychological Medicine at Glasgow 
University and has been reviewed by the West of Scotland Research Ethics Committee to 
ensure to ensure scientific and ethical conduct. The study has also received organisational 
approval from the Beatson West of Scotland Cancer Centre. 
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Contact for further information 
 
 
If you have any questions or would like to discuss this with me before making your 
decision, you can contact me: Shehnaz Iqbal, Trainee Clinical Psychologist, Mental Health 
and Wellbeing, 1st floor, Administration Building, Gartnavel Royal Hospital, 1055 Great 
Western Road, GLASGOW G12 0XH. Also contactable by telephone : 0141 301 7324 
and email:  siqbal.2@research.gla.ac.uk 
 
Can I speak with someone not directly involved in the study? 
 
 
If you wish to speak with someone not directly involved in the study about any aspect of the 
research process then you can contact Dr Kenneth Mullen Mental Health and Wellbeing, 
1st floor, Administration Building, Gartnavel Royal Hospital, 1055 Great Western Road, 
GLASGOW G12 0XH. Also contactable via telephone: 0141 211 3932 and email  
Kenneth.mullen@glasgow.ac.uk. Thank you for taking the time to read this information. 
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Appendix 2.7: Participant Consent Form 
 
 
 
 
 
 
 
 
 
 
 
 
Factors Influencing Patient Recall and Understanding of Haemato-Oncology 
Consultations: An exploratory study. 
 
 
 
 
 
Participant Consent Form 
 
 
 
 
 
 
 
 
Correspondence to: 
 
Shehnaz Iqbal 
Trainee Clinical Psychologist Mental 
Health and Wellbeing 
1st floor, Administration Building 
Gartnavel Royal Hospital 
1055 Great Western Road GLASGOW 
G12 0XH 
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FACTORS INFLUENCING PATIENT RECALL AND 
UNDERSTANDING OF HAEMATO-ONCOLOGY 
CONSULTATIONS 
Participant Consent Form 
 
 
Please put your initials in each of the boxes to show that you have read and are in 
agreement with the statements: 
 
1 . I confirm that I have read and understand the information sheet (Version 2.0 date: 
19/12/2012) for the above study and have had the opportunity to ask questions 
 
2. I understand that my participation is voluntary and that I am free to 
withdraw at any time, without giving a reason, without my medical care or 
legal rights being affected 
 
3. I understand that the medical clinician who is involved in my care 
(Doctor or Nurse at the hospital) will be informed of my participation in 
the research 
 
4. I understand that my medical consultation and subsequent interview, will be taped 
using a digital recording device, solely for the purpose of the research study as described 
in the Participant Information Sheet and will be kept confidential 
 
5. I understand that quotations may be published but that all names, places and 
identifiers will be  removed once all the information  has been gathered 
 
6. I understand that relevant sections of my medical notes and data collected during 
the study may be looked at by individuals from regulatory authorities, the University 
of Glasgow, or from 
NHS Greater Glasgow and Clyde, where it is relevant to my taking part in this research 
 
 
7. I agree to take part in the above study 
 
 
Name of Participant Date Signature    
 
 
Researcher Date Signature    
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Thank you for taking part in this study 
(1 copy for participant and researcher and 1 copy for medical notes) 
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Appendix 2.8   Major Research Project Proposal 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Factors Influencing Patient Recall and Understanding of Haemato-Oncology Consultations: An 
exploratory study. 
 
 
Major Research Project Proposal 
 
 
 
 
 
 
 
 
Correspondence to: 
 
Shehnaz Iqbal 
Trainee Clinical Psychologist 
Mental Health and Wellbeing 
1st floor, Administration Building 
Gartnavel Royal Hospital 
1055 Great Western 
Road GLASGOW G12 
0XH 
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1. Introduction 
 
 
 
1.1 Background 
 
 
 
Hematopoietic stem cell transplantation (HSCT) is a form of treatment used with patients 
diagnosed with leukaemia. Leukaemia is one of the most aggressive forms of cancer (Cancer 
Research UK, 2011) - categorised into two main types: chronic (chronic lymphocytic leukaemia 
(CLL) or chronic  myelogenous leukaemia (CML)) and acute (acute lymphoblastic leukaemia 
(ALL) or acute  myelogenous leukaemia (AML)) leukaemia. The primary aim of HSCT is to 
eliminate the leukaemia cells completely, allowing permanent regeneration of bone marrow by 
healthy and normal bone marrow cells. There are three sources of stem cells; 1) bone marrow 
2) cord blood or 3) peripheral blood. 
 
 
 
There are two main types of transplantation: autologous and allogeneic. During autologous 
transplant the patient's own marrow or peripheral blood stem cells are used. This is different 
from allogeneic transplant when the patient receives bone marrow or peripheral blood stem 
cells (PBSC) from a matched sibling or unrelated/voluntary donor (VUD). Allogeneic 
transplant patients will form the sample of the present study. 
 
 
 
Stem cells for allogeneic transplant can be harvested from bone marrow from the donor’s hip 
bone under general anaesthetic or taken from blood following injections of granulocyte colony 
stimulating factor (G-CSF
1
). The donor's blood is drawn and reserved using an apheresis 
machine (blood cell separator). The patient receives aggressive, high dose chemotherapy and 
occasionally radiotherapy to destroy any cancer cells. This is called conditioning treatment. 
Afterwards, the stem cells (originally sourced from the donor) are processed and transfused into 
the patient to restore cells of the body that have been destroyed by conditioning treatment. 
 
 
 
HSCT is associated with a number of serious emotional and physical complications that can 
significantly reduce patient’s quality of life, most notably graft vs. host disease (GvHD) (Gratwohl 
et al. 2010). GvHD is a life-threatening immune reaction whereby cells from the donor's immune 
system are  recognized  by  the  patient's  body  and  rejected.      Acute  GvHD  develops  
immediately  after 
 
 
1 
Growth factor (G-CSF )- stimulates movement of stem cells from the bone marrow into the bloodstream 
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transplant and is usually managed with drugs, including steroids to further suppress the new 
immune system and reduce symptoms. Whilst HSCT remains a dangerous procedure, associated 
with potentially fatal consequences, it also offers hope of cure when other cancer treatments 
have been unsuccessful (Gratwohl et al. 2010). Prior to consenting to HSCT, patients attend 
medical consultations, during which they are informed about the potentially curative effects (e.g. 
chance of survival) of HSCT as well as possible life threatening risks (e.g. GvHD). At worst, 
patients have to accept the risk of dying as a result of HSCT and not of the disease itself (Grulke & 
Bailer, 2010). 
 
 
 
1.2 Communication in Cancer Care 
 
The National Institute of Clinical Excellence (NICE, 2003) guidelines for haematological 
cancers advocate patient centred care through clear and accurate dissemination of treatment options  
to patients, so they can make informed decisions about cancer care and treatment. The quality of 
this interaction can be evaluated by measuring patient’s recall and understanding of information 
given to them during consultations (Carlson et al. 2005). Patient’s recall of cancer treatment 
consultations has previously been defined and measured empirically (Fallowfield et al. 1999; 
Carlson et al., 2005; Jenkins et al., 2009). Although the research literature fails to provide a clear 
operational definition of patient understanding of cancer treatment, the concept has been measured 
(Jenkins et al. 2008). 
 
 
1.3 Factors influencing doctor-patient interaction 
 
Ley’s model (1988) of effective communication emphasises the relationship between patient’s 
memory, understanding and satisfaction on recall during medical consultations. Kessels (2003) 
reported that 40-80% of medical information presented by health care professionals was 
forgotten immediately by patients; influenced by a combination of consultant (i.e. use of medical 
terminology) and patient factors (i.e. emotional state and older age) including having received 
previous cancer treatments, which may have resulted in cognitive impairment (Friedman et al. 
2009). Thus, many variables can influence doctor-patient interactions, including both patient and 
iatrogenic factors. The current and brief review of literature shall only consider factors 
intrinsic to patients that are of relevance to the present study. 
 
 
1.4 Cognitive impairment 
 
Many allogeneic transplant patients will have received chemotherapy regimens at an earlier stage 
in the treatment of their disease. Research demonstrates that cancer survivors who have received 
radiotherapy  and  chemotherapy  can  experience  impaired  cognition  as  a  consequence  of  
these 
 127 
treatments (Joly et al. 2011). Asher’s (2011) review of cognitive dysfunction among cancer 
survivors reported that individuals with acute leukemias and myleodysplastic syndrome have 
impairments before treatment, including deficits in memory and learning, processing speed, 
aspects of executive functioning and upper limb dexterity. This review also suggests that 
cognitive dysfunction may also be explained by anxiety, depression and fatigue which are 
problems commonly experienced by this population. 
 
 
 
 
1.5 Anxiety 
 
Anxiety may inhibit or facilitate recall and understanding of information given during medical 
consultations. Kessels (2003) explains this phenomeonon in terms of “attentional narrowing”. 
This occurs when information or events perceived as aversive (e.g. side effects of treatment) 
become the primary focus of attention. This may cause anxiety and limit patient’s attention 
towards information perceived as being less important, allowing them to “focus on” concerning 
aspects of information and thereby experience enhanced recall of it. Information perceived as 
upsetting, may cause patients to become overwhelmed and this may impact adversley upon their 
ability to cognitively process information they receive during consultations. Patients may believe 
that they lack information, consequently causing feelings of uncertainty, anxiety and depresssion 
(Ong, 2000). Both very high and low levels of anxiety can lead to lower recall of information 
with moderate levels resulting in optimal performance on tests of recall (Ley, 1988). 
 
 
1.6 Depression 
 
Patients with advanced cancer often experience strong emotions such as sadness, anxiety, and 
fear throughout the course of their illness (Derogatis et al. 1983) which can impair memory 
function (Blaney, 1986) and impact negatively upon their ability to recall information during 
cancer consultations (Carlson. et al 2005). Specifically, Kizilbash et al. (2002) reported that 
depressive symptoms (with or without anxiety) have a negative effect on immediate recall of 
new information and amount of acquisition but not on retrieval or retention. Given that HSCT 
consultations contain medical (new information) and highly emotive information, then it is 
plausible to assume that degree of depression will have an adverse effect on patient’s recall and 
understanding of new information presented to them during consultation. 
 
 
1.7 HSCT consultations 
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Whilst communication has been researched extensively within the field of oncology (Rodriguez et 
al. 2010), few studies have investigated communication processes that occur within HSCT 
consultations (Jenkins et al. 2011) and fewer still with individuals diagnosed with acute leukaemias 
following their consultations for HSCT (Merckaert et al., 2009; Grulke and Bailer, 2010; 
Alexander et al., 2012). Consultations about HSCT tend to be longer due to the complexity and 
amount of information which needs to be given to transplant recipients regarding treatment 
options, processes and long-term side- effects, giving rise to a higher frequency of giving and 
receiving of communication behaviours than in other settings (Alexander et al. 2012). No research 
to date has investigated the influence of patient factors, in particular level of cognitive ability, on 
patient recall and understanding of HSCT consultations. 
2. Aim and objectives 
 
 
 
2.1 Aim 
 
To explore the recall and understanding of information given during a consultation with a 
Haemato- Oncologist, of patients who are due to undergo VUD transplant for (acute or chronic) 
leukaemia. 
 
 
2.2 Objectives 
 
 
 
Using semi-structured interviews and a qualitative approach, the study will investigate patients’ 
recall and understanding of their HSCT consultation. This will be accomplished by: 
 
 
1) Identifying how much information from the consultation is recalled accurately, as well as 
identifying the types of information that either tend to be recalled or not recalled 
 
 
 
2) Having identified the key areas of information, to be given in the consultation by prior discussion 
with the consultant, to examine level of patients’ understanding of these areas by eliciting 
patient’s knowledge/understanding through the use of focused questions 
 
 
 
3) In addition, to provide a context for the patients’ performance, possible influences on the 
patients’ recall and understanding of the consultation will be assessed through evaluation of 
patients’ anxiety, depression and memory function. 
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3. Plan of investigation 
 
 
 
Due to the researchers’ limited knowledge of HSCT, permission was granted by the local 
clinical governance committee, for her to observe consultations to gain an understanding of how 
clinics are conducted prior to commencing the study. This was considered by the committee as 
service evaluation, providing that, consent was obtained from patient’s and consultants, 
consultations were not tape-recorded and all subsequent work and the main application would be 
subject to full ethics application. 
 
 
 
A coding framework (the recall and understanding interview template (RUIT)) was developed 
for recording and scoring agreement between information conveyed by the consultant and 
information recalled and understood by the patient. This task was aided by the researchers’ 
observations of HSCT consultations prior to commencing recruitment as well as other key sources. 
 
3.2 Sample 
 
 
 
All first visit patient’s eligible for VUD HSCT with a diagnosis of acute/chronic leukaemia 
and referred consecutively to the Beatson West of Scotland Cancer Centre (BWoSCC). The 
BWoSCC database indicates that approximately 8 AML/ALL VUD transplants patients are 
recruitable within a 6 month period. 
 
3.3 Justification of sample size 
 
 
Methods employed in previous research were not sufficiently comparable due to variations in 
sample sizes that do not consistently fulfil requirements for statistical power (Merkaert et al. 
2009; Mystakidou, 2009). Within qualitative research, sample size is not predetermined; 
therefore power calculations are not appropriate. Contrary to quantative research which provides 
the best opportunity to generalize results to the population, the essence of qualitative research, is to 
gain an in-depth, rich and complex understanding of the meanings patients attribute to their 
experience from their perspective (Fagerlind et al. 2012) and in the context of the current 
research, provide insight into the population required to make decisions about HSCT. Instead of 
placing the elements of a consultation in predefined categories, using this approach, themes are 
established based on the data while coding 
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(3). Therefore purposive, convenience sampling will be used who meet selection criteria (3.4). 
This sampling technique means that the number of cases is not predetermined, however based 
on the referral rate, recruitment time-frame of participants and research design of the present study, 
a sample size of 8 participant’s was deemed feasible. 
 
 
 
3.4 Inclusion/Exclusion criteria 
Inclusion criteria. Participants have to be; 
 
 candidates for HSCT 
 at least 18 years old 
 express awareness of their diagnosis 
 have English as their first language. 
 
 
 
Exclusion criteria. Patients with; 
 
 severe psychiatric morbidity 
 substance misuse 
 no capacity to give informed consent 
 
 
 
3.5 Recruitment procedures (Figure 1) 
 
 
 
Participants referred for HSCT to the BWoSCC between January 2013 and June 2013 and 
identified as meeting inclusion criteria will be sent an invitation letter with an attached ‘consent to 
be contacted by researcher’ form alongside their hospital letter for initial clinic appointment. 
Participants interested in taking part can return the consent form via a stamped addressed envelope 
to the researcher who will contact participants individually and explain the process fully. 
Interested participants will then be given a participant information sheet, full consent form and 
relevant pre-consultation questionnaires to complete on the day of their HSCT appointment. This 
process will be outlined in the Participant Information Sheet and in the instruction sheet included in 
the questionnaire pack. 
 
 
 
3.6 Design 
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A cross-sectional within subjects’ cohort design will be used to evaluate the objectives. 
 
 
 
3.7 Research procedures 
 
 
 
On the day of the patient’s medical appointment, the researcher will introduce herself to the 
patient, explain the research procedure, obtain the informed consent form and collect the 
completed questionnaires. The medical consultation (approximately 1 hour), shall be digitally 
recorded. The digital voice recorder (DVR) will be placed in the clinic room and started prior to 
the participant and consultant entering the room by the researcher. Following the consultation, and 
once the participant leaves the clinic room; the DVR will be collected by the researcher. The 
researcher will then interview the participant using the RUIT in a separate clinic room. This 
interview will also be recorded. Every effort will be made to work around patients schedules. The 
option of conducting post- consultation RUIT interviews over the telephone will be given for 
patient’s convenience and to decrease burden. Consent to record the consultation will also be 
sought from the individual Consultant Haemato-Oncologist. Figure 1 shows a preliminary outline of 
the participant’s recruitment and participation in the study. 
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3.8 Figure 1. Flow chart of patient journey through process of recruitment 
 
 
 
(insert flow chart) 
 
 
 
3.9 Measures 
 
To better understand the target population and factors that impact on their recall and 
understanding individually the following measures will be used: 
 
1. Hospital Anxiety and Depression Scale (HADS, Zigmund & Snaith, 1983). A self-
administered scale, containing two separable scales: depression and anxiety. The scale has 14 
items in total (seven covering depression and seven covering anxiety). The maximum score for each 
subscale is 21. For the HADS depression subscale (HADS-D), a score of 10 is the recommended 
threshold for considering intervention. 
 
 
2. Functional Assessment of Cancer Therapy–Cognitive Function (FACT Cog). (Wagner et al. 
2005) Using a criterion of two or more times a week, individuals complete 50 items related to 
memory function and 4 of these items invite them to report perceptions of others i.e. “Other 
People Noticed Deficits”. 
 
In addition to the above measures, participants’ age, gender, years of formal education, 
previous exposure to cancer treatments, instances of traumatic brain injury and clinically 
significant scores from the above self-report outcome measures will also be summarised and 
presented in tabular form to contextualise participants’ performance. This information will be 
obtained from participants’ casenotes which will be hand searched following ethical approval from 
the Beatson West of Scotland Cancer Centre Ethics Committee (BWoSCCEC). 
 
 
 
3.10 Analysis of RUIT for HSCT Consultations 
 
 
 
Research recommends that patients are interviewed immediately after consultations for optimal 
performance on tests of recall (Carlson et al. 2005), where possible, this will be followed. 
However, to reduce the risk of overwhelming patients, assessment of patient recall and 
understanding will occur individually with the researcher at a convenient time point between the 
first and second consultation. The RUIT will be used as a template, from which the 
researcher will base her semi-structured interview to compare their level of recall and 
understanding against established key topics. The RUIT will be used with actual participants’ to 
identify level of concordance of what was explained/defined and what the patient correctly 
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understood and recollected. The questions will be open-ended to allow for participants’ individual 
interpretation and exploration of the key topics of information transmitted by the consultant during 
consultation. These will be followed up by targeted questions to obtain further information 
about key topics. The semi-structured format is considered appropriate to explore individuals’ 
perceptions of doctor patient communication and the factors influencing it (Carlson et al., 2005). 
Patient interviews will take between 20-30 minutes. The interview will be digitally recorded, 
uploaded onto the laptop and transcribed verbatim, anonymising any references to person or place. 
 
 
 
Directed Content analysis will be used to code and analyse recall and understanding of the 
communication from the consultation (Carlson et al., 2005) using pre-determined categories from 
the RUIT. This will involve coding and analysing the level of concordance between information 
given by the Consultant during consultation and individual patients’ recall and understanding of 
this, using the RUIT. Coding will be conducted manually. Although coding may begin 
immediately due to coding schemes having been established (Hsieh and Shannon, 2005) through 
the RUIT, the researcher will begin to identify and categorise all instances of recall and 
understanding, by reading the transcript and highlighting all the text that on first impression 
appears to represent a unit of recall and/or understanding. This is to capture all the possible 
occurrences of the phenomenon and may increase trustworthiness of the coding framework (Hsieh 
and Shannon, 2005). The next step in analysis will be to code all highlighted passages using 
predetermined codes from the RUIT. Any text that may not be categorised with the initial coding 
scheme will be given a new code. Participants will also be asked if they have consulted any other 
resources (e.g. carer/internet regarding information), and if so, what the content of this was to 
account for any additional sources of biases. To limit researcher subjectivity and bias, the coded 
framework and content of each participant’s interview will be reviewed by the academic 
supervisor in addition to the researcher themselves. 
 
 
4. Settings and Equipment 
 
 
Setting: 
BWoSCC outpatient clinic. 
 
 
Equipment: 
Outcome measures, recall interview schedule, envelopes, password encrypted laptop, DVR, 
digital recording equipment (x2) and telephone recording device for telephone interviews. 
 
4.1 Health and safety issues 
 
Researcher safety issues: 
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It is not anticipated that there will be any risks to the researcher whilst conducting the 
study. Meetings with participants will be conducted at BWoSCC, within staffed areas and standard 
working hours. The researcher will engage in supervision with Field Supervisor, Dr Christopher 
Hewitt as a routine to ensure any emotional distress is managed effectively and minimised. 
 
Participant safety issues: 
 
 
The researcher will do her best to provide a comfortable setting for participants during 
research interviews. Participants may become distressed or fatigued as a consequence or during the 
process of discussing distressing information. The researcher is a trainee clinical psychologist, 
trained to ensure distress is managed sensitively and supportively. To ensure distress is minimised, 
participants will be reminded that before commencing interviewing they can stop at any time or 
choose not to answer any of the questions. They will also be given the opportunity of break/stop 
the interview. Should participants become distressed this will be managed to the best of the 
trainee’s ability and the option of further psychological support will be given in the form of 
Clinical Psychology provision based within the BWoSCC. Permission will be sought from the 
patient that should the researcher become aware of any aspects of the consultation that have not 
been understood, she can give a list of the problem areas to their consultant so that the consultant 
can address them with the patient at their next appointment. 
 
5. Ethical issues 
 
 
Ethical approval will be sought from the West of Scotland Research Ethics Committee having 
obtained approval from the Beatson Clinical Trials Executive Committee. A patient 
information leaflet will be sent out indicating that participation is entirely voluntary. Refusal to 
take part in the study will in no way impact ongoing medical care. Participants who do not wish 
to take part in the study do not need to return the consent form. A reminder of confidentiality and 
the right to withdraw will remain open throughout the study. The Principal Investigator will 
ensure that the study will be carried out in accordance with the ethical principles in the 
Research Governance Framework for Health and Community Care (2006) and applicable legal and 
regulatory requirements. 
 
 
 
5.1 Informed consent 
Patients will be provided with both verbal and written information regarding the study. 
Written information will outline the reasons for the study and precautions regarding protection 
of patient’s confidentiality. Should risk arise during the study, participants’ GP/consultant will be 
informed. Any contact with GP/consultant will be discussed with the participant beforehand 
135  
and the participant information sheet will outline this procedure for potential participants. 
 
6. Data protection 
 
 
Data will be stored electronically on an NHS password encrypted University laptop. All 
paperwork will be stored in a locked filing cabinet at the University. Personal identifiers will be 
removed from data and a unique code assigned to each patient. 
 
6.1 Research conduct 
 
 
Further discussion of research as well as areas of concern can also be addressed by research 
supervisors should patients/carers wish as information sheets will provide their contact details. 
 
6.2 Financial and indemnity issues 
 
 
 
Sufficient funding is available for the researcher to carry out the research. NHS employed 
researchers are covered for negligent harm through the NHS Clinical Negligence and Other Risks 
Scheme (CNORIS) indemnity scheme. 
 
 
7. Practical applications 
 
 
 
To identify factors that influence recall and understanding of patient consultations and 
consider mediums to facilitate patient recall thus enhance decision making about treatment. 
 
 
8. Planned dissemination of research results 
 
 
 
The results of the study will be written up and submitted to the West of Scotland Doctorate in 
Clinical Psychology Programme for assessment purposes. It is hoped that the final results and 
conclusions of the study will be published in a scientific journal. 
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Appendix 2.9 Semi-Structured Interview Schedule 
 
FACTORS INFLUENCING PATIENT RECALL AND UNDERSTANDING 
OF HAEMATO-ONCOLOGY CONSULTATIONS 
 
 
Recall and Understanding Interview Template (RUIT) 
 
 
 
 
Researcher introduces self to the patient and asks if they would be prepared to answer a 
few questions about their experience of their consultation and the information they were 
given by the consultant. 
 
 
If yes: ask the patient if they have time to do this immediately. 
If yes, but not now: thank the participant for their time and confirm contact details to arrange 
an alternative date/time prior to their next appointment at the Beatson. 
 
 
If no: thank the participant for their time. 
 
 
Immediately prior to commencing the recall and understanding interview, say to the patient 
“I am going to ask you some questions about how much you can remember from your 
consultation from (say date). Is that okay with you? We are asking you these questions to 
try and find out what patients remember and understand about what the doctor said to them 
about transplant. This is not a test of your memory but rather to learn more about factors 
that might influence how much information you can remember, and the types of 
information  that patients tend to forget after their hospital consultations about bone 
marrow transplant (BMT). This type of research might help to identify factors that 
influence recall and understanding of medical information, and help us to think of ways 
we could help patients gain as much as possible from their appointments.” 
 
 
The researcher may also explain about confidentiality and limits to this at this point. 
The researcher will advise the patient that they can take a break at any time 
throughout the interview should they feel unable to continue for whatever reason. They 
may also recommence the interview and/or reschedule at a more convenient time if 
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their distress is such that they do not wish to continue. They will also be reminded of their 
right to withdraw from participation in the study at any point and that this will in no way 
effect their ongoing treatment. Patients will also be reminded of the availability of further 
psychological support via the Clinical Psychology Service at the Beatson should this be 
required. 
 
Ask the patient if they have any information about cancer or their summaries near them and 
if they do ask if they could put them out of sight. 
 
Note: where a patient asks for further information e.g. if they remember the doctor 
said something but cannot remember the details, explain to the patient that I am unable to 
give this kind of information, because I am not a member of the bone marrow transplant 
team and do not have a medical background, so will be unable to answer any questions 
about their care and treatment. Let them know that I will take a note of their 
questions/comments and should they be agreeable, pass them onto their consultant who will 
be able to answer their questions. 
 
 
Part 1: Spontaneous Recall 
 
 
Say to the patient “can you talk me through everything you remember the doctor saying 
to you during your consultation (date)?” 
When the patient stops talking, say “can you remember anything else?” and continue to 
ask this until the patient cannot remember any further information and move onto the 
prompted recall section. 
Can you let me know about what, if any, sources of information you have looked at 
since your initial consultation? What did you learn about transplant/your illness? 
 
 
Part 2: Prompted Recall 
 
 
Once the patient has given all the information that they are able to remember in the 
spontaneous recall section say to the patient: 
“I am now going to ask you some more specific questions about what the doctor said to see 
if that helps you to remember anything you haven’t mentioned so far. Is that ok? You do 
not have to repeat anything you have already said, but it does not matter if you do. Not 
all the questions will necessarily apply to you, but I am going to ask all the questions 
I have so don’t worry if you answer no to any of the questions.” 
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There are questions below each of the categories and suggested prompts. The prompts 
are deliberately vague to avoid leading the patient and are often just a rewording of the 
original question. The prompts should be used until the patient cannot provide any further 
information. in any given category. 
 
There are also examples of possible responses under each category. These are examples only 
and the lists are not exhaustive. They are to give an idea of the types of information that 
could fit into each category. For some categories there will only be one possible response 
(e.g. type of transplant) and for others there are many possible responses (e.g. side-effects). In 
addition, some of the categories will have fairly standard responses (e.g. process of 
transplant) whereas other categories will be more individual to the patient (e.g. practicalities 
of treatments). 
 
 
We do not need to know all the possible answers in any given category because for 
each patient we will have all possible correct answers from the consultation recording. 
 
 
Categories of information 
 
 
 
1. Information about the patient’s current/past health status - cancer (e.g. type/size) 
 
 
Did the consultant talk with you about your health condition/illness? What do you 
remember the doctor telling you about your health condition/illness? 
 
If yes: where the patient remembers details: ask for further information e.g. do you 
know what that means? Can you remember anything else? 
 
Proceed to category 2 
 
If no: Where the patient does not remember any details: prompt with e.g. did the 
doctor mention anything about what kind of cancer you have, for example 
 
Examples: 
1. Type 
- Leukaemia – AML, ALL, CML , CLL, 
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- Lymphoma etc etc 
 
 
2. Stage 
- Progression of cancer 
- Protein status 
- Grade 
 
 
2. Treatment optionsDo you remember the doctor telling you anything about the 
treatment(s) that are available to you for the cancer? Do you know what treatment 
the consultant has recommended/considering you for? 
 
 
If yes: ask for further information e.g. “what is that?” “Did the doctor mention 
anything else?” 
 
 
If no: we would expect patients to know at least the main treatment they are going to 
have, however if the patient says they do not know ask “are you coming back to the 
hospital? Do you know why you are coming back? 
 
 
Examples: 
a) Transplant 
- Bone marrow transplant a) from voluntary donor (VUD) b) from sibling autologous (auto) 
b) Conditioning treatment (radiotherapy and chemotherapy) 
c) Other 
- Cyclosporine 
- Other immunosuppressant’s/anti-viral drugs 
- Childhood vaccinations 
 
3. Aims of treatment 
 
 
Do you remember what (if anything) the doctor told you about the aims of this treatment? 
Do you know what other treatment (s) you will be given as well as transplant? 
 
 
If yes: do you know what that means? Did the doctor say anything else about the aims 
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of these treatments? 
 
 
If no: do you remember if the doctor said why they suggested that you to consider 
this treatment? 
 
 
Note if the patient answered category 2 with more than one treatment ask: did the 
doctor mention anything about the aims of (other treatments) 
 
 
Examples 
a) Conditioning treatment 
- remove any remaining cancerous cells 
 
 
b) Transplant 
- give the body a new immune system 
- cure the cancer 
- reduce the chance of recurrence 
 
 
4. Side effects of treatment 
 
 
Do you remember the doctor telling you anything about possible side effects of having 
this treatment? 
 
 
If yes: can you remember if the doctor mentioned any other side effects? 
 
 
If no: do you remember if the doctor said the treatment might have any effects on you 
that were not to do with the cancer? 
Note: if the patient answered category 2 with more than one treatment and answers 
this category referring to only one treatment ask: did the doctor mention anything about 
possible side effects of (other treatment)? 
 
 
Examples of possible answers: 
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1. Conditioning treatment: diarrhoea, fever, hair loss, nausea/vomiting, recovery time, 
mucositis, infection risk, cataracts, infertility, reduced white blood cell count, thyroid, loss 
of libido 2
nd 
cancers, depression, extreme tiredness, lack of concentration, focus 
 
 
2. Transplant: diarrhoea, fever, hair loss, nausea/vomiting, graft failure/ Chronic/acute 
Graft vs. host disease (GvHD) recovery time, mucositis, infection risk, cataracts,  
infertility, reduced white blood cell count, thyroid, loss of libido, increased risk of 2
nd 
cancers, depression, extreme tiredness, lack of concentration, focus 
3. Immuno suppressants/vaccines/anti-biotic 
 
 
5. Graft vs. Hosts Disease (GvHD) 
 
 
Do you remember if your consultant spoke with you about a significant post transplant risk 
of graft vs. host’s disease? Did they talk about the (2 main – acute/chronic) types of GvHD? 
 
 
If yes: ask for further information 
 
 
If no: prompt further e.g. did the consultant mention anything about the possibility of 
you contracting illness/infection after the transplant procedure? Do you remember the 
doctor telling you there are things you should or should not be doing? Why was that? 
 
 
If the patient answered category 2 with more than one treatment and answers this 
category referring to only one treatment ask “did the doctor mention anything about what 
life might be like for you and your family after the transplant?” 
 
 
Examples: 
-  It’s like the new immune system that rejects your body 
 
 
6. Prognostic discussion related to risk of mortality/chances of cure 
 
 
Do you remember the consultant telling you anything about your chances of 
cure/survival with and without this (these) treatment (s)? 
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Examples: 
- % cure/survival 
 
- Recovery time , to be realistic and based on your age, previous illness, health 
you have X percentage of survival/cure 
 
- This tends to be an aggressive treatment and there is 50% chance of mortality in 
the first 3 months 
7. Impact of treatment on quality of life 
 
 
Do you remember if your consultant spoke with you about your quality of life/course 
of recovery? Did he/she speak with you about the level of support required after the 
operation? 
 
 
If yes: ask for further information 
 
 
If no: prompt further e.g. Do you remember the doctor telling you there are things you 
should or should not be doing after transplant? Are you considering going back to 
work, do you know how long that will take? Why was that? 
 
 
Note: the responses to this question might be more individual e.g. quality of life may 
depend on things like type of job, level of family support etc. 
 
 
If the patient answered category 2 with more than one treatment and answers this 
category referring to only one treatment ask “did the doctor mention anything about what 
life might be like for you and your family after the transplant? 
 
 
Examples: 
- Support with hospital visits/ transplant after care 
- Current living arrangements 
- Financial matters 
 
 
8. Practical issues regarding treatment (e.g. when, where, how often, etc) 
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Do you remember if the doctor told you anything about the practicalities of having 
this (these) treatment (s)? Did they mention anything about how they administer the 
treatment? 
 
 
How long it would take? Whether there are things you should or should not do? Or 
anything else like that? 
 
 
If yes: ask for further information 
If no: prompt further e.g. are you coming back to the hospital, do you know how often 
you will have to come back and why? Do you remember the doctor telling you there are 
things you should or should not be doing? Why was that? 
 
 
Note: the responses to this question might be more individual e.g. practicalities may 
include things like recovery duration, return to work etc. 
 
 
If the patient answered category 2 with more than one treatment and answers this 
category referring to only one treatment ask “did the doctor mention anything about the 
practicalities of having (other treatment)? 
 
 
Examples 
1. Chemotherapy – treatment 
- Length of treatment 
- No of visits 
2. Radiotherapy – treatment 
 
 
9. Role in decision making and treatment recommendations 
 
 
Did you feel you were/are able to make an informed decision about treatment based on 
the information you were given? 
 
 
If yes: ask for more information 
 
 
If no: ask did you receive information about treatment that was enough to help you decide 
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if transplant is for you or not? 
 
 
10. Other tests/treatments 
 
 
Do you remember if the doctor mentioned anything about other possible treatments or 
trials that you may be eligible for? 
 
 
If yes: ask for more information 
If no: say to the patient are you aware of options other than transplant available here at 
the hospital or elsewhere? 
 
 
11. Next steps 
 
 
Did the consultant make you aware of what tests you need to complete? Did they talk 
about the next steps for you in this process of considering transplant? 
 
 
If yes: ask for more information 
 
 
If no: usually we would expect patients to know that they are going for further tests or have 
completed them e.g. liver function. However, if the patient cannot remember then ask 
about what tests have already been completed at the Beatson. 
 
 
Examples: 
- I am going/been for liver, kidney function/blood tests 
- I am going to have a look around the unit 
 
 
Ending 
 
 
Thank the participant for their time and effort during the interview. Emphasise that they 
can receive the results of the study if they so wish. Ask them for their preferred method of 
contact for this information. Participant information sheet has contact details on them 
should they wish to raise anything about the study with Researcher. 
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Appendix 3: Recall and Understanding Information Template (RUIT) Adjustments 
 
 
 
Revision. Delete this category as it is information requested by the doctor from 
the patient, not given to them, therefore cannot be evaluated. 
 
 
 
1. information pertainin g to patient’s curr ent/past he alth and well bein g   
Clarification of the following: 
 
a.   what the patient understands about their illness 
b.  purpose of consultation 
c.type and stage of illness 
d. how the patient has responded to previous treatment e.g. remission status 
e.   medical history – including any current medications 
f. what is the patient’s current health/dental status – including alcohol, smoking and 
exercise 
g.current employment arrangements 
h. home situation, availability of home and social supports 
 
 
2. Treatment 
Explanation of 
process: 
 
a. indications  for  VUD  transplant  –  suitability  of  illness  type/stage,  age,  
donor availability, disease in remission (BMA), fitness. 
b. How is a VUD transplant different from previous treatments may have received? 
c. Tests required pre-transplant and reasons for these – heart, lung, kidney, liver 
d. Finding a suitable matched donor, VUD or sibling 
e. Notice period for donor. Likely transplant dates 
f. Stem cell harvesting – how this happens, how much is needed 
g. Conditioning treatments – reduced intentsity/Myeloblative; what agents are used, 
over what period of time 
h. What happens – IV transfusion of cells through Hickman line 
i. Anticipated length of hospital admission – indications of when suitable for discharge 
 
3. Aims of treatment 
a. explanation of purpose and intention of transplant 
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4. side-effects of treatment 
 
 
Acute effects 
a. what to expect – week 1, weeks 2-3, week 4-5 
including following: high temperature, rash, rigors, mucosistis, stomach/abdominal pain, 
diarrohea, nausea/vomiting, fatigue, hair loss, reduced concentration/memory, increased 
infection risk 
Revision. Delete categories 4c & 4D as it this is covered in the remainder of section 4. 
 
b. side-effects of steroids – lose muscle, gain fat, increased BP 
etc c.   side effects of immune-suppressive therapy 
d. management of side effects 
e. estimation of length of time takes for immune system to recover 
f. risk of complications diminishing over 
time Late effects 
 
g. endocrine, cardio-vascular, secondary cancers, fertility, loss of libido, cataracts 
h. how these are screened for and managed – i.e. late effects clinic 
i. preventative behaviours – stop smoking, high factor sun protection, bowel screening 
 
 
5. Graft vs. Host Disease (GvHD) 
Acute GvHD 
 
a. what is it/why does it happen? 
b. Grading 
c. Symptoms – skin, liver, gut, appetite etc 
d. Chances of acquiring acute GvHD – mild, moderate, severe 
e. How this is prevented/managed 
f. Implications of GvHD 
g. Graft vs. Leukaemia Effect – explanation and implications 
 
 
Chronic GvHD 
 
h. symptoms 
i. management 
j. prognostic discussion 
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establish what information the patient requires 
 
k. treatment related mortality 
l. relapse 
m. disease free survival 
n. estimation of morbidity/mortality without transplant 
 
 
6. impact of treatment of quality of life 
a. physical This item is covered in topics 2 -5. 
b. psychological 
c. social 
d. financial/vocational 
 
 
7. practical issues 
a. named consultant/team approach 
b. clean environment – issues around visitors, young children, single room, infection 
control – aprons, hand gel 
c. relative overnight accommodation 
d. transport 
e. donor lymphocyte infusion 
f. long-term anti-microbial therapy 
g. change of blood group 
h. re-immunisation 
i. sperm banking 
j. possible need for re admission 
k. friends of the Beatson 
l. outpatient follow up arrangements 
m. support needs post discharge 
 
 
8. Next steps 
a. consent form – read over 
b. have a look around the unit 
c. read over booklet before next appointment 
d. take bloods 
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Appendix 3.1: Participant coding sheet 
 
Participant 2 Coding sheet Coder: Shehnaz 
Iqbal Test: 1 
 
Coding Key: 2=complete 1a=partial 
recall 1b=distorted recall 0a=omission 
0b=fabrication/intrusion 
 
1 Treatment Notes Code 
A    
B    
C    
D    
E    
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F    
G    
H    
I    
 
 
 
2 Transplant aims   
A    
 
 
 
3 Side effects   
A    
B    
C    
D    
E    
F    
149  
 
G    
H    
I    
 
 
 
 
 
4 GvHD   
A    
B    
C    
D    
E    
F    
G    
H    
150  
I    
151  
 
J    
K    
L    
 
 
 
5 Prognostic discussion   
A    
B    
C    
D    
 
 
 
6 Qol   
A    
B    
C    
152  
D    
153  
 
E    
F    
G    
H    
 
 
 
7 Practical issues   
A    
B    
C    
D    
E    
F    
G    
H    
154  
I    
155  
 
J    
K    
L    
M    
 
 
 
 
 
8 Next steps   
A    
B    
C    
D    
 
 
Additional relevant comments 
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Appendix 3.2 Coded sheet 
 
 
Coding Key: 2=complete 
1a=partial recall 
1b=distorted recall 
0a=omission 
0b=fabrication/intrusion 
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Phase 1: content 
analysed & grouped 
according to 9 RUIT 
topics 
Phase 2: separation of 
patient and consultant 
data into RUIT categories 
Patient Consultant Phase 3: coding & 
reaching agreement 
Treatment 1   Code 
Patient  accurately 
recalled indications for 
VUD transplant; 
suitability,   donor 
availability and 
requirement of remission 
A There are 3 different factors 
that would be whether or 
not we can get my 
Leukaemia into remission it 
wont get a transplant until 
its in remission  so what i 
will be doing is next week a 
will be getting different 
chemo therapy to try and 
get it into remission if that 
is the case then i would 
have to get a suitable 
donor from somewhere that 
would match ma body and 
then the treatment would be 
more aggressive  than the 
chemotherapy. i will have 
to get the chemo from my 
own hospital and its only if i 
go into remission that a will 
get a transplant em. 
said before a suitable 
donor, remission, fitness to 
take the treatment. 
2 – all 3 coders agreed on 
level of concordance 
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Patient able to 
discriminate how a VU 
transplant is different 
from previous treatments 
B Can have a transplant but 
that would only be on 
condition of the...as he said 
before   a   suitable   donor, 
not as straightforward as 
recovering from chemo 
there is the potential for a 
lot  of  hiccups   along  the 
0a 2 – recoded & 
agreement reached on 
complete recall thereon, as 
participant       able        to 
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they have had  remission, fitness to take the 
treatment. The other option 
is more chemo that would 
put it into remission for 
about a year or more but it 
wouldn’t offer a cure long 
term. 
way. A transplant can cure 
the L where the chemo 
couldn’t. Issue with 
transplant is that it is a 
demanding process to go 
through in some ways more 
demanding than chemo you 
had already. 
distinguish that transplant 
has the potential to cure 
the Leukemia, whereas 
chemotherapy wouldn’t in 
the long term. 
Tests required pre 
transplant and reasons for 
these 
C  Your fit enough for a 
transplant if all tests looked 
okay, heart lung and 
kidneys. You would see 
irregularity of the liver or it 
might be enlarged because 
drinking might have caused 
some damage but no 
evidence of that in any of 
your blood tests. That can 
be done in hospital for your 
next lot of chemo 
0a – participant omitted, 
when asked, information 
pertaining to tests required 
pre transplant and reasons 
for these. 
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Finding a suitable 
matched donor, sibling or 
VUD 
D If I went into remission, 
then I would have to get a 
suitable donor from 
somewhere that would 
match ma body and then the 
treatment would be more 
aggressive than 
chemotherapy 
We don’t yet have a donor 
but there are a number of 
possibilities. There are 
enough potential donors 
there tat we could find you a 
good match. Your disease at 
the time of transplant would 
need to be better contolled, 
give you different treatment 
to bring you back into 
remission.    In    terms    of 
1a – the participant 
partially recalled, as they 
identified a VUD 
transplant would be 
necessary, the intensity of 
transplant and suitability 
of the donor but not 
significance of matching 
in relation to the immune 
system      and      possible 
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   matching we have to find a 
donor that matches your 
immune system as  closely 
as possible. Even if there 
was a brother or sister that 
was a match there would 
still be lots of differences 
between the immune system 
s and certainly when you 
are using an unrelated donor 
there’s likely to be even 
more differences . The only 
immune system that would 
be identical to you would be 
an identical twin. There will 
always be differences there 
and sometimes they will be 
recognised sometimes not 
rejection. 
Notice period for donor. 
Likely transplant dates 
E I wont get a transplant until 
its (leukemia) in remission. 
So what I will be doing next 
week is trying a different 
chemo therapy to try and 
get it into remission 
In an ideal world we would 
want to do is wait until your 
blood counts recover and 
look into your bone arrow. 
Get your chemo, get time at 
home before bringing  you 
in for transplant 
2 – consultant did not give 
exact time frames as 
participant required 
chemotherapy  for 
remission before specific 
dates can be given for 
transplant. 
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Stem cell harvesting F gonna be half a litre can’t 
remember what he said but 
it was quite a considerable 
amount it wasn’t just little 
When you get a bone 
marrow sample taken 
normally take a few ml of 
BM. Need to collect half a 
2 – participant able to 
identify how this happens 
and how much is needed. 
Whilst  growth  factor  use 
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  samples like a few millitres 
as they had been taken so i 
wonder that’s what they can 
do if the stem cell are there 
with the whatever it is the 
immune system of the host 
donor then em it will grow 
itself basically so they don’t 
need to remove so much 
from the donor em 
litre of BM that can be quite 
tricky sometimes it involves 
the donor getting an 
anaesthetic. The bone 
marrow being collected 
from lots of points in their 
pelvis 
is mentioned it was felt by 
the coders that the 
information recalled was 
sufficient to warrant a 
score of 2. 
Conditioning treatments 
(e.g. chemotherapy) 
G it’s another course of 
chemotherapy. Okay. But a 
take it won’t be so 
aggressive so i wouldn’t 
recover from it. Okay. 
. pre treatment would kill 
off all your immune system 
so that the stem cell 
transfusion would  have 
some of the anti bodies and 
some of the what you call it 
system immune  system 
from the donor so that 
would come into my system 
You get prepared firstly 
normally over 7-8  days of 
chemotherapy similar to 
that, you will get next week, 
wont be exactly the same 
will be a few differences. 
The current chemotherapy 
you get is capped at a a 
level that will allow the 
bone marrow to  recover. 
For transplant it is at a 
higher level cause don’t 
want bone marrow to 
recover after treatment 
2 participant recalled 
information completely, 
indicating the need for 
conditioning  treatment 
and the purpose. All 
coders agreed on this. 
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What happens – IV 
transfusion of cells 
through Hickman line 
H Would just be like a blood 
transfusion okay. Its 
however many litres or half 
a litre or something eh 
liquid just actually 
administered via 
Few bags of cells that go up 
in a drip through a Hickman 
line to your BM. So there’s 
no injection or operation the 
transplant is really a 
transfusion.    These    stem 
2. As above 
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  intravenous transfusion like 
blood transfusion but eh 
how long would it take did 
they say.... aw its like i 
don’t know about transplant 
but the chemo lasts for 10 
days right. 
So whatever pre treatment it 
was like very aggressive 
chemo would get here to 
kill off everything so that 
host em stem cell 
transfusion could be 
thingied into a blank sort of 
canvas as it were. So that 
you wouldn’t have any of 
your own bone marrow or 
you wouldn’t have any 
leukaemia cells, blood cells 
or anything would be all the 
new stuff put in. So that’s 
what would happen for the 
first few 
cells find their way to your 
bone marrow and make new 
blood cells for you. 
 
Anticipated length of 
hospital admission – 
indications of when 
suitable for discharge 
I in  hospital  like  from  3-6 
weeks 
You will be ready get home 
4-6 weeks after transplant. 
2  1a  Participant  partially 
recalled this information 
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Appendix 3.3: Recall and understanding information template (RUIT) coding 
guidelines 
The coding procedure 
 
Transcripts ought to be coded by 2 or more coders, enlisting the support of either the field 
or researcher supervisor or principal investigator of this study. It is intended that coders 
follow these guidelines to enhance the reliability of their findings. However, when 
coding it is important to bear in mind that absence of similar findings does not 
provide grounds for refutation, particularly when consistencies in the application of codes 
across data sets exits, which arguable can contribute to increased confidence in the 
findings of the study. The guidelines for coding are organised so that coders can gain 
confidence and reliability as they gain independence. 
 
1. The lead coder will provide coded examples of each RUIT topic. 
2. Both sets of transcripts ought to be read between 3-4 times (Figure 1). Enlist the 
help of an additional skilled researcher/coder to audit each consultation and 
interview transcript to ensure accuracy. 
3. Learn the RUIT topics, corresponding items, and codes through discussion with 
a member of the research team. 
4. To allow data to be compared, create 2 columns corresponding to each RUIT 
category, into which consultant information and patient recall and understanding 
of the same information can be separated. 
5. RUIT topic categories and associated items can be identified on the 
consultation transcripts on a line by line basis and by indicating RUIT topic number 
in the margins of the transcripts (see appendix 2.2). Similarly RUIT topic numbers 
were also applied to the interview transcripts. 
 
Figure 1. Example of sentence by sentence coding from consultation 
 
 
Consultation transcript text Interview transcript text 
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Consultant: From then on its a case of dealing 
with effects of treatment and dealing with effects 
of the transplant. Idea of the chemo is to suppress 
your Immune System and Bone Marrow it will 
stop your Bone Marrow (BM) working and will 
4etake 2/3 weeks for the new BM to be working 
during that time your blood counts going to drop 
down to very low levels so your not going to have 
white cells in your blood and those are important 
for protecting you from infection. Platelets help 
your blood to clot. So you won’t have any 
platelets so 4cyou will be at increased risk of 
infection and you’re going to be at increased risk 
of bleeding. You might need blood transfusions 
and so you’re very vulnerable and so you’re 
looked  after  in  a  room  in  the  transplant  unit 
4P: He said there would be risk of infection more so in first 3 
months. But longer you go on less chance of infection. You 
could feel dizzy; vomiting catch coughs colds and all these 
kinds of things. You’re going to feel ill more  immediately 
after. Score=1b 
 
 
 
Recall and Understanding codes 
 
2 = complete; 1a = partial recall, 1b distorted recall; 0a = omission, 0b = fabrication/intrusion 
 
 
Figure 2. Example coding sheet 
 
 
 Participant 1 Coding sheet 
Coder: Researcher 1 
Test: 1 
 
 
 
 
Coding Key: 
2=complete 
1a=partial recall 
1b=distorted recall 
0a=omission 
0b=fabrication/intrusion 
    
specially designed to protect you from infection. 
During the time from transplant – no problem 
wondering around ward but wouldn’t want you 
leaving the ward cause your in an 8benvironment 
that’s designed to protect you and keep you safe 
no problem getting visitors as long as they don’t 
have coughs and colds or upset tummies. 
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 1 Current/past well-being Notes Code  
 A     
 B     
 C     
 D     
 E     
 F     
 G     
 H     
 
 
 
 
 
2 
 
A 
B 
C 
D 
E 
F 
G 
H 
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Treatment 
 
 
 
 
 
Notes 
 
 
 
 
 
Code 
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6. Patient data can be compared with consultant’s data to establish level of agreement. In 
the original coding and analysis level of recall is established by counting the “bits” of 
information given by the consultant under each topic and the corresponding “bits” of 
information recalled by the patient. Apply the following codes to evaluate level of 
both recall and understanding. To differentiate between errors of commission (e.g. 
misunderstandings) and errors of omission, sub-codes were devised from the 
following 3 level structures: 2 = complete; 1a = partial recall, 1b distorted recall; 0a = 
omission, 0b = fabrication/intrusion 
7. Subsequent to data preparation and organisation onto the coding sheet, create 
an additional column (see below). 
 
 
Figure 3. Example coding excerpt from coding sheet 
 
 
2. 
Explanation 
of treatment 
Category Patient 
transcript 
Consultant 
transcript 
Code assigned 
Patient able  to 
discriminate how a 
HSCT transplant is 
different  from 
previous treatments
  they 
have           had 
B Can have a transplant 
but that would only be 
on condition of the...as 
he said before a 
suitable donor, 
remission, fitness to 
take the treatment. The 
other option is more 
chemo that would put 
it into remission for 
about a year or more 
but it wouldn’t offer a 
cure long term. 
not as straightforward as 
recovering from chemo 
there is the potential for a 
lot of hiccups along the 
way. A transplant can cure 
the leukemia where the 
chemo couldn’t. Issue with 
transplant is that it is a 
demanding process to go 
through in some ways 
more demanding than 
chemo you had already. 
0a 2 – recoded & 
agreement reached on 
complete recall thereon, 
as participant able to 
distinguish that 
transplant has the 
potential to cure the 
Leukemia, whereas 
chemotherapy wouldn’t 
in the long term. 
 
 
8. Figure 3 shows how the coding system can be applied in practice. Researchers ought 
to create their own examples of each segment and then review precoded conversations 
against each RUIT topic to ensure that coders capture level of recall and understanding 
regarding a topic and associated items. 
9. Coders ought to ‘team-code’, reading through transcripts together and recording the 
presence of topics, associated items and level of recall and understanding. At this 
point coders must decide if they are establishing level of recall and understanding based on 
3 Transplant aims   
A    
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verbatim recall or if ‘getting the gist’ is enough. Coders ought to make field notes 
available, where necessary, to maintain an audit trail. 
10. Finally, each coder should code an individual consultation and participant transcript, 
and this      should      be      reviewed      by      the      lead      coder      on      a      weekly      
basis.
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Appendix 3.4 Inter-rater agreement by RUIT category and associated items 
 
 
              
Treatment – 
explanation of 
process 
a) 
Indicati 
ons for 
VUD 
transpla 
nt 
b) 
Differe 
nce 
betwee 
n VUD 
and 
previo 
us 
treatm 
ent 
c) Medical tests 
required prior to 
transplant 
d) Finding 
suitable 
donor 
e) Notice 
and 
transplant 
dates 
f) Stem 
cell 
harvestin 
g 
g) 
conditioni 
ng 
treatment 
h) IV 
transfusion 
i) Length 
of hospital 
stay 
    
0.67 0.68 1.0 1.0 0.67 0.67 1.0 1.0 0.545 1.0     
Aims of 
treatment 
0.55             
Side effects of 
treatment 
What 
to 
expect 
weeks 
1-5 
Side 
effects 
of 
steroid 
s 
Estimation of 
length recovery 
time for immune 
system 
Risk of 
compicati 
ons 
diminishin 
g over 
time 
Late 
effects 
How 
these are 
manage 
Preventati 
ve 
behaivour 
s 
      
0.95 1.0 1.0 1.0 0.61 1.0 1.0 1.0       
Graft vs host 
disease 
What 
this is 
Gradin 
g 
Symptoms Possibility 
of 
acquiring 
GvHD 
Managem 
ent of 
GvHD 
Implicati 
ons of 
GvHD 
Graft vs 
leukemia 
effect 
Chronic 
symptoms 
Managem 
ent 
    
0.876 0.67 1.0 1.0 1.0 1.0 1.0 0.54 0.54 0.54     
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Prognostic 
discussion 
Treatm 
ent 
mortalit 
Relaps 
e 
Disease free 
survival 
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 y             
0.829 0.428 1.0 1.0           
Impact of 
treatment on 
QoL 
Psychol 
ogical 
Social Financial/vocati 
onal 
          
0.815 1.0 1.0 0.642           
Practical issues Named 
consult 
ant/tea 
m 
approac 
h 
Clean 
enviro 
nment 
Relative 
overnight 
accommodation 
Transport Donor 
lymphocy 
te infusion 
Long 
term anti 
microbial 
therapy 
Change of 
blood 
group 
Reimmunisat 
ion 
Sperm 
banking 
Need for 
readmissi 
on 
Frien 
ds of 
beatso 
n 
Outpatie 
nt 
follow 
up 
Support 
needs 
dischar 
ge 
0.95 0.565 0.736 1.0 1.0 1.0 1.0 1.0 1.0  1.0 1.0 1.0 1.0 
Next steps Consen 
t form 
Unit 
tour 
Booklet Take 
bloods 
         
1.0 1.0 1.0 1.0 1.0          
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